AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Health FacilitiesSkilled Nursing FacilitiesEarly Detection of CancerResidential FacilitiesProstatic NeoplasmsOvarian NeoplasmsBreast NeoplasmsLung NeoplasmsStomach NeoplasmsColonic NeoplasmsAmbulatory Care FacilitiesFacility Design and ConstructionNeoplasm MetastasisNeoplasm InvasivenessUnited StatesNeoplasmsPancreatic NeoplasmsAssisted Living FacilitiesGene Expression Regulation, NeoplasticMice, NudeCancer VaccinesHealth Facility AdministrationRetrospective StudiesHealth Facilities, ProprietaryNeoplasm ProteinsUterine Cervical NeoplasmsSurvival AnalysisSurvival RatePublic FacilitiesHealth Facility PlanningPrognosisGenetic Predisposition to DiseaseProspective StudiesFollow-Up StudiesRiskAntineoplastic AgentsFacility Regulation and ControlRegistriesAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmCarcinoma, Squamous CellCarcinomaDisease ProgressionReverse Transcriptase Polymerase Chain ReactionRisk AssessmentUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungNational Cancer Institute (U.S.)QuestionnairesColorectal NeoplasmsCell Line, TumorGene Expression ProfilingReceptors, EstrogenXenograft Model Antitumor AssaysAge FactorsLong-Term CareTumor Markers, BiologicalNeoplasm StagingMutationSurvivorsOdds RatioRNA, MessengerRisk FactorsReceptor, erbB-2Rectal NeoplasmsNursing HomesNeoplasm Recurrence, LocalCombined Modality TherapyBlotting, WesternMultivariate AnalysisSensitivity and SpecificityNeoplasm TransplantationDisease-Free SurvivalProstate-Specific AntigenDNA, NeoplasmMammographyCell Transformation, NeoplasticEndometrial NeoplasmsSmokingRNA, Small InterferingLogistic ModelsDNA MethylationHealth Services AccessibilityAqueous HumorChemotherapy, AdjuvantMedical OncologyCell SurvivalToilet FacilitiesTumor Suppressor Protein p53Esophageal NeoplasmsFluorouracilMilitary FacilitiesGenotypeTamoxifenTransplantation, HeterologousNeoplastic Stem CellsJapanKaplan-Meier EstimateCisplatinReceptors, ProgesteroneAntineoplastic Agents, PhytogenicOligonucleotide Array Sequence AnalysisReproducibility of ResultsCell MovementGenes, BRCA1Antineoplastic Agents, HormonalDown-RegulationAntigens, NeoplasmSEER ProgramBreastDose-Response Relationship, DrugLiver NeoplasmsIncidenceClinical Trials as TopicAdenocarcinomaTumor BurdenDrug Screening Assays, AntitumorHead and Neck NeoplasmsCancer Care FacilitiesCell DivisionAnticarcinogenic AgentsPredictive Value of TestsNeoplasms, Radiation-InducedMouth NeoplasmsConfidence IntervalsNeoplasms, Hormone-DependentTreatment OutcomePolymorphism, GeneticCell CycleHomes for the AgedMolecular Targeted TherapyCarcinoma, Small CellCross-Sectional StudiesPaclitaxelOccupational ExposurePolymerase Chain ReactionCell ProliferationCell Growth ProcessesApoptosisPromoter Regions, GeneticQuality of LifeAmerican Cancer SocietyBone NeoplasmsReceptor, Epidermal Growth FactorRadiotherapyNeoplasms, Second PrimaryMicroRNAsTransfectionChinaProstateNeoplasms, Glandular and EpithelialRNA InterferenceAntibodies, MonoclonalNeovascularization, PathologicTumor Suppressor ProteinsUp-RegulationModels, BiologicalGene SilencingIntermediate Care FacilitiesSkin NeoplasmsGenes, Tumor SuppressorTumor Cells, CulturedTime FactorsGenital Neoplasms, FemaleDeoxycytidineTrabecular MeshworkGerm-Line MutationPrecancerous ConditionsGenes, NeoplasmNeoplasm GradingMice, SCIDDietTissue Array AnalysisGastrointestinal NeoplasmsAge DistributionPalliative CareAntimetabolites, AntineoplasticQuality of Health CareBase SequenceGenes, p53Receptors, AndrogenAnimals, LaboratoryPostmenopausePrevalenceSocioeconomic FactorsMaternal Health ServicesHealth Facility EnvironmentMolecular Sequence DataTaxoidsHCT116 CellsDrug Administration ScheduleMCF-7 CellsThyroid NeoplasmsRNA, NeoplasmDNA-Binding ProteinsEuropean Continental Ancestry GroupFlow CytometryOccupational DiseasesGene ExpressionImmunoenzyme TechniquesGene Knockdown Techniques
Health Facilities: Institutions which provide medical or health-related services.Skilled Nursing Facilities: Extended care facilities which provide skilled nursing care or rehabilitation services for inpatients on a daily basis.Early Detection of Cancer: Methods to identify and characterize cancer in the early stages of disease and predict tumor behavior.Residential Facilities: Long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.Prostatic Neoplasms: Tumors or cancer of the PROSTATE.Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.Breast Neoplasms: Tumors or cancer of the human BREAST.Lung Neoplasms: Tumors or cancer of the LUNG.Stomach Neoplasms: Tumors or cancer of the STOMACH.Colonic Neoplasms: Tumors or cancer of the COLON.Ambulatory Care Facilities: Those facilities which administer health services to individuals who do not require hospitalization or institutionalization.Facility Design and Construction: Architecture, exterior and interior design, and construction of facilities other than hospitals, e.g., dental schools, medical schools, ambulatory care clinics, and specified units of health care facilities. The concept also includes architecture, design, and construction of specialized contained, controlled, or closed research environments including those of space labs and stations.Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.Neoplasm Invasiveness: Ability of neoplasms to infiltrate and actively destroy surrounding tissue.United StatesNeoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).Assisted Living Facilities: A housing and health care alternative combining independence with personal care. It provides a combination of housing, personalized supportive services and health care designed to meet the needs, both scheduled and unscheduled, of those who need help with activities of daily living. (www.alfa.org)Gene Expression Regulation, Neoplastic: Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.Mice, Nude: Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.Cancer Vaccines: Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced.Health Facility Administration: Management of the organization of HEALTH FACILITIES.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Health Facilities, Proprietary: Health care institutions operated by private groups or corporations for a profit.Neoplasm Proteins: Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.Survival Analysis: A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.Survival Rate: The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.Public Facilities: An area of recreation or hygiene for use by the public.Health Facility Planning: Areawide planning for health care institutions on the basis of projected consumer need.Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Genetic Predisposition to Disease: A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Risk: The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.Antineoplastic Agents: Substances that inhibit or prevent the proliferation of NEOPLASMS.Facility Regulation and Control: Formal voluntary or governmental procedures and standards required of hospitals and health or other facilities to improve operating efficiency, and for the protection of the consumer.Registries: The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers.Antineoplastic Combined Chemotherapy Protocols: The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.Drug Resistance, Neoplasm: Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)Disease Progression: The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.Reverse Transcriptase Polymerase Chain Reaction: A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.Risk Assessment: The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.Carcinoma, Non-Small-Cell Lung: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.National Cancer Institute (U.S.): Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research with the objective of cancer prevention, early stage identification and elimination. This Institute was established in 1937.Questionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.Cell Line, Tumor: A cell line derived from cultured tumor cells.Gene Expression Profiling: The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.Receptors, Estrogen: Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.Xenograft Model Antitumor Assays: In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness.Age Factors: Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.Long-Term Care: Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care.Tumor Markers, Biological: Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.Neoplasm Staging: Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.Mutation: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.Survivors: Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition as well as family members, significant others, or individuals surviving traumatic life events.Odds Ratio: The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.RNA, Messenger: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Receptor, erbB-2: A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.Rectal Neoplasms: Tumors or cancer of the RECTUM.Nursing Homes: Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization.Neoplasm Recurrence, Local: The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.Combined Modality Therapy: The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.Blotting, Western: Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.Multivariate Analysis: A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)Neoplasm Transplantation: Experimental transplantation of neoplasms in laboratory animals for research purposes.Disease-Free Survival: Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.Prostate-Specific Antigen: A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.DNA, Neoplasm: DNA present in neoplastic tissue.Mammography: Radiographic examination of the breast.Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.Smoking: Inhaling and exhaling the smoke of burning TOBACCO.RNA, Small Interfering: Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.Logistic Models: Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.DNA Methylation: Addition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.Health Services Accessibility: The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive care and services from the health care system. Factors influencing this ability include geographic, architectural, transportational, and financial considerations, among others.Aqueous Humor: The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319)Chemotherapy, Adjuvant: Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.Medical Oncology: A subspecialty of internal medicine concerned with the study of neoplasms.Cell Survival: The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.Toilet Facilities: Facilities provided for human excretion, often with accompanying handwashing facilities.Tumor Suppressor Protein p53: Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER.Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.Military Facilities: Areas designated for use by the armed forces personnel.Genotype: The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.Tamoxifen: One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.Transplantation, Heterologous: Transplantation between animals of different species.Neoplastic Stem Cells: Highly proliferative, self-renewing, and colony-forming stem cells which give rise to NEOPLASMS.JapanKaplan-Meier Estimate: A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)Cisplatin: An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.Receptors, Progesterone: Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.Antineoplastic Agents, Phytogenic: Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.Oligonucleotide Array Sequence Analysis: Hybridization of a nucleic acid sample to a very large set of OLIGONUCLEOTIDE PROBES, which have been attached individually in columns and rows to a solid support, to determine a BASE SEQUENCE, or to detect variations in a gene sequence, GENE EXPRESSION, or for GENE MAPPING.Reproducibility of Results: The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.Cell Movement: The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.Genes, BRCA1: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.Antineoplastic Agents, Hormonal: Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)Down-Regulation: A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.Antigens, Neoplasm: Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.SEER Program: A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)Breast: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.Dose-Response Relationship, Drug: The relationship between the dose of an administered drug and the response of the organism to the drug.Liver Neoplasms: Tumors or cancer of the LIVER.Incidence: The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.Clinical Trials as Topic: Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Tumor Burden: The total amount (cell number, weight, size or volume) of tumor cells or tissue in the body.Drug Screening Assays, Antitumor: Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)Cancer Care Facilities: Institutions specializing in the care of cancer patients.Cell Division: The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.Anticarcinogenic Agents: Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.Predictive Value of Tests: In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.Neoplasms, Radiation-Induced: Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.Mouth Neoplasms: Tumors or cancer of the MOUTH.Confidence Intervals: A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable.Neoplasms, Hormone-Dependent: Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Polymorphism, Genetic: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.Cell Cycle: The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE.Homes for the Aged: Geriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.Molecular Targeted Therapy: Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)Cross-Sectional Studies: Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.Paclitaxel: A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death.Occupational Exposure: The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation.Polymerase Chain Reaction: In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.Cell Proliferation: All of the processes involved in increasing CELL NUMBER including CELL DIVISION.Cell Growth Processes: Processes required for CELL ENLARGEMENT and CELL PROLIFERATION.Apoptosis: One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.Promoter Regions, Genetic: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.Quality of Life: A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.American Cancer Society: A voluntary organization concerned with the prevention and treatment of cancer through education and research.Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.Receptor, Epidermal Growth Factor: A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF-related peptides including TRANSFORMING GROWTH FACTOR ALPHA; AMPHIREGULIN; and HEPARIN-BINDING EGF-LIKE GROWTH FACTOR. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.Radiotherapy: The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.Neoplasms, Second Primary: Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.MicroRNAs: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.Transfection: The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.China: A country spanning from central Asia to the Pacific Ocean.Prostate: A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.Neoplasms, Glandular and Epithelial: Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.RNA Interference: A gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process.Antibodies, Monoclonal: Antibodies produced by a single clone of cells.Neovascularization, Pathologic: A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.Tumor Suppressor Proteins: Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.Up-Regulation: A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.Models, Biological: Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.Gene Silencing: Interruption or suppression of the expression of a gene at transcriptional or translational levels.Intermediate Care Facilities: Institutions which provide health-related care and services to individuals who do not require the degree of care which hospitals or skilled nursing facilities provide, but because of their physical or mental condition require care and services above the level of room and board.Skin Neoplasms: Tumors or cancer of the SKIN.Genes, Tumor Suppressor: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.Tumor Cells, Cultured: Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Genital Neoplasms, Female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).DeoxycytidineTrabecular Meshwork: A porelike structure surrounding the entire circumference of the anterior chamber through which aqueous humor circulates to the canal of Schlemm.Germ-Line Mutation: Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells (i.e., "generative" cells ancestral to the gametes) are transmitted to progeny while those in somatic cells are not.Precancerous Conditions: Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)Genes, Neoplasm: Genes whose abnormal expression, or MUTATION are associated with the development, growth, or progression of NEOPLASMS.Neoplasm Grading: Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.Mice, SCID: Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice.Diet: Regular course of eating and drinking adopted by a person or animal.Tissue Array Analysis: The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.Gastrointestinal Neoplasms: Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.Age Distribution: The frequency of different ages or age groups in a given population. The distribution may refer to either how many or what proportion of the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.Palliative Care: Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed)Antimetabolites, Antineoplastic: Antimetabolites that are useful in cancer chemotherapy.Quality of Health Care: The levels of excellence which characterize the health service or health care provided based on accepted standards of quality.Base Sequence: The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.Genes, p53: Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53.Receptors, Androgen: Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.Animals, LaboratoryPostmenopause: The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.Prevalence: The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.Socioeconomic Factors: Social and economic factors that characterize the individual or group within the social structure.Maternal Health Services: Organized services to provide health care to expectant and nursing mothers.Health Facility Environment: Physical surroundings or conditions of a hospital or other health facility and influence of these factors on patients and staff.Molecular Sequence Data: Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.Taxoids: A group of diterpenoid CYCLODECANES named for the taxanes that were discovered in the TAXUS tree. The action on MICROTUBULES has made some of them useful as ANTINEOPLASTIC AGENTS.HCT116 Cells: Human COLORECTAL CARCINOMA cell line.Drug Administration Schedule: Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.MCF-7 Cells: An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.RNA, Neoplasm: RNA present in neoplastic tissue.DNA-Binding Proteins: Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.European Continental Ancestry Group: Individuals whose ancestral origins are in the continent of Europe.Flow Cytometry: Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.Occupational Diseases: Diseases caused by factors involved in one's employment.Gene Expression: The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.Immunoenzyme Techniques: Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.Gene Knockdown Techniques: The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES.

Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture. (1/430)

The purpose of this study was to review the progress in clinical and translational research in chronic myelogenous leukemia (CML) over the past 20 years at M.D. Anderson Cancer Center. The CML database updating the clinical and basic research investigations was reviewed as the source of this report. Publications resulting from these investigations were summarized. The long-term results with intensive chemotherapy, IFN-alpha therapy alone or in combination, autologous stem cell transplantation, and new agents such as homoharringtonine and decitabine showed encouraging results. Biological studies related to the BCR-ABL molecular abnormality, other molecular events, and the detection of minimal residual disease were detailed. Future strategies with potential promise in CML were outlined. Significant progress in understanding CML biology and in treating patients afflicted with the disease has occurred. Several therapeutic and research tools are currently investigated, which should hopefully improve further the prognosis of patients with CML.  (+info)

Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East. (2/430)

BACKGROUND: Axillary lymph node dissection is an important procedure in the surgical treatment of breast cancer. Axillary lymph node dissection is still performed in over half of breast cancer patients having histologically negative nodes, regardless of the morbidity in terms of axillary pain, numbness and lymphedema. The first regional lymph nodes draining a primary tumor are the sentinel lymph nodes. Sentinel node biopsy is a promising surgical technique for predicting histological findings in the remaining axillary lymph nodes, especially in patients with clinically node-negative breast cancer, and a worldwide feasibility study is currently in progress. METHODS: Intraoperative lymphatic mapping and sentinel node biopsy were performed in the axilla by subcutaneous injection of blue dye (indigocarmine) in 88 cases of stage 0-IIIB breast cancer. Sentinel lymph nodes were identified by detecting blue-staining lymph nodes or dye-filled lymphatic tracts after total or partial mastectomy. Finally, axillary lymph node dissection was performed up to Levels I and II or more. RESULTS: Sentinel lymph nodes were successfully identified in 65 of the 88 cases (74%). In the final histological examination, the sentinel lymph nodes in 40 cases were negative, including four cases with non-sentinel-node-positive breast cancer (specificity, 100%; sensitivity, 86%). In nine (31%) of the 29 cases with histologically node-positive breast cancer, the sentinel lymph nodes were the only lymph nodes affected. Axillary lymph node status was accurately predicted in 61 (94%) of the 65 cases. CONCLUSIONS: Although it was the initial experience at the National Cancer Center Hospital East, sentinel node biopsy proved feasible and successful. This method may be a reasonable alternative to the standard axillary lymph node dissection in patients with early breast cancer.  (+info)

Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. (3/430)

BACKGROUND: Because metastatic nonseminomatous germ cell cancer is a rare but treatable cancer, we have explored whether there is an association between the experience of the treating institution with this disease and the long-term clinical outcome of the patients, particularly patients with a poor prognosis. METHODS: We analyzed data on 380 patients treated in one of 49 institutions participating in the European Organization for Research and Treatment of Cancer/ Medical Research Council randomized trial of four cycles of bleomycin-etoposide-cisplatin followed by two cycles of etoposide-cisplatin versus three cycles of bleomycin-vincristine-cisplatin followed by three cycles of etoposide-ifosfamide-cisplatin-bleomycin, both treatment regimens given with or without filgrastim (granulocyte colony-stimulating factor). Institutions were divided into four groups based on the total number of patients entered in the trial. The groups were compared by use of the Cox proportional hazards model stratified for treatment with filgrastim and for patient prognosis as defined by the International Germ Cell Consensus Classification Group. With the use of this classification, only 65 % of the patients had a poor prognosis. RESULTS: Patients treated in the 26 institutions that entered fewer than five patients into the trial had an overall survival that was statistically significantly worse (two-sided P = .010; hazard ratio = 1.85; 95% confidence interval = 1.16-3.03) than that of patients treated in the 23 institutions that entered five patients or more. Overall survival and failure-free survival were similar among institutions that entered at least five patients. The observed effect may be related to differences in adherence to the chemotherapy protocol and in the frequency and extent of surgery for residual masses, although only the differences in dose intensity achieved statistical significance. CONCLUSIONS: Patients treated in institutions that entered fewer than five patients into the trial appeared to have poorer survival than those treated in institutions that entered a larger number of patients with "poor-prognosis" nonseminoma.  (+info)

Incremental costs of enrolling cancer patients in clinical trials: a population-based study. (4/430)

BACKGROUND: Payment for care provided as part of clinical research has become less predictable as a result of managed care. Because little is known at present about how entry into cancer trials affects the cost of care for cancer patients, we conducted a matched case-control comparison of the incremental medical costs attributable to participation in cancer treatment trials. METHODS: Case patients were residents of Olmsted County, MN, who entered phase II or phase III cancer treatment trials at the Mayo Clinic from 1988 through 1994. Control patients were patients who did not enter trials but who were eligible on the basis of tumor registry matching and medical record review. Sixty-one matched pairs were followed for up to 5 years after the date of trial entry for case patients or from an equivalent date for control patients. Hospital, physician, and ancillary service costs were estimated from a population-based cost database developed at the Mayo Clinic. RESULTS: Trial enrollees incurred modestly (no more than 10%) higher costs over various follow-up periods. The mean cumulative 5-year cost in 1995 inflation-adjusted U.S. dollars among trial enrollees after adjustment for censoring was $46424 compared with $44 133 for control patients. After 1 year, trial enrollee costs were $24645 compared with $23 964 for control patients. CONCLUSIONS: This study suggests that cancer chemotherapy trials may not imply budget-breaking costs. Cancer itself is a high-cost illness. Clinical protocols may add relatively little to that cost.  (+info)

Influence of data display formats on physician investigators' decisions to stop clinical trials: prospective trial with repeated measures. (5/430)

OBJECTIVE: To examine the effect of the method of data display on physician investigators' decisions to stop hypothetical clinical trials for an unplanned statistical analysis. DESIGN: Prospective, mixed model design with variables between subjects and within subjects (repeated measures). SETTING: Comprehensive cancer centre. PARTICIPANTS: 34 physicians, stratified by academic rank, who were conducting clinical trials. INTERVENTIONS: PARTICIPANTS were shown tables, pie charts, bar graphs, and icon displays containing hypothetical data from a clinical trial and were asked to decide whether to continue the trial or stop for an unplanned statistical analysis. MAIN OUTCOME MEASURE: Percentage of accurate decisions with each type of display. RESULTS: Accuracy of decisions was affected by the type of data display and positive or negative framing of the data. More correct decisions were made with icon displays than with tables, pie charts, and bar graphs (82% v 68%, 56%, and 43%, respectively; P=0.03) and when data were negatively framed rather than positively framed in tables (93% v 47%; P=0.004). CONCLUSIONS: Clinical investigators' decisions can be affected by factors unrelated to the actual data. In the design of clinical trials information systems, careful consideration should be given to the method by which data are framed and displayed in order to reduce the impact of these extraneous factors.  (+info)

An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre. (6/430)

Ovarian cancer is the commonest cause of gynaecological cancer death in the UK, and guidelines for initial surgery and staging of this disease are widely available. We report a retrospective audit of the surgical management of patients with newly diagnosed ovarian cancer referred to the Christie Cancer Centre in Manchester in 1996. The aim was to assess compliance with surgical guidelines. The authors found that the majority of patients (92%) presented via an outpatient clinic and for these individuals surgery was therefore elective. This mode of presentation should allow management by a small number of dedicated gynaecologists at each hospital, but up to seven consultants in each hospital performed surgery on a relatively small number of patients. Furthermore, less than half the patients underwent the recommended surgical procedure. Although some patients may have 'inoperable' disease, these data suggest that a greater compliance with national and international guidelines are required to provide an optimal level of care.  (+info)

A comprehensive assessment of satisfaction with care: preliminary psychometric analysis in an oncology institute in Italy. (7/430)

BACKGROUND: Little is known about patients' perception of the quality of the care they receive in oncology hospitals. We developed a 61-item comprehensive assessment of satisfaction with care (CASC) to evaluate the competence of hospital physicians and nurses, as well as aspects of care organisation and hospital environment. The aims of this study were to define the structure of the CASC and assess the internal consistency and convergent and discriminant validity of its scales. PATIENTS AND METHODS: Three hundred ninety-five consecutive cancer patients discharged from an oncology institute in Italy were asked to complete the CASC at home and return it in a self-addressed envelope. RESULTS: Two percent of the patients refused to participate and 25% failed to return the questionnaire. Separate factor analyses of the CASC sub-scales disclosed the perceived extent of doctors' and nurses' availability, coordination, human quality, technical competence, provision of psychosocial care and information, as well as the patients' general satisfaction, perception of the organisation of their care, access and comfort. Multi-trait scaling analysis was carried out on item-grouping resulting from factor analyses. High levels of internal consistency and convergent validity were obtained but discriminant validity could be improved. CONCLUSIONS: Results of present psychometric testing of the CASC forecast adequate properties. This will be confirmed by repeating these analyses in a cross-cultural setting.  (+info)

Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. (8/430)

Although nosocomial transmission of human respiratory syncytial virus (HRSV) and its effect on morbidity and mortality among immunocompromised adults are well recognized, few studies have applied molecular techniques to differentiate nosocomial from community-acquired infections. Between January and April 1997, an outbreak of HRSV occurred among adult patients in a leukemia/lymphoma ward. Among 45 hospitalized patients undergoing bronchoscopy for investigation of acute respiratory illness, 8 were identified with HRSV infection. One infected patient developed symptoms before admission and was thought to be the index case. However, subsequent sequencing of 7 HRSV isolates identified 2 distinct genotypes, GA5 (1 case) and GB3 (6 cases). The 6 GB3 isolates could be further differentiated into 2 strains with identical nucleotide sequences that differed from each other and from 14 community HRSV isolates. Instead of a single nosocomial outbreak of HRSV, multiple introductions of HRSV likely occurred with distinct lines of nosocomial transmission.  (+info)

AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Health FacilitiesSkilled Nursing FacilitiesEarly Detection of CancerResidential FacilitiesProstatic NeoplasmsOvarian NeoplasmsBreast NeoplasmsLung NeoplasmsStomach NeoplasmsColonic NeoplasmsAmbulatory Care FacilitiesFacility Design and ConstructionNeoplasm MetastasisNeoplasm InvasivenessUnited StatesNeoplasmsPancreatic NeoplasmsAssisted Living FacilitiesGene Expression Regulation, NeoplasticMice, NudeCancer VaccinesHealth Facility AdministrationRetrospective StudiesHealth Facilities, ProprietaryNeoplasm ProteinsUterine Cervical NeoplasmsSurvival AnalysisSurvival RatePublic FacilitiesHealth Facility PlanningPrognosisGenetic Predisposition to DiseaseProspective StudiesFollow-Up StudiesRiskAntineoplastic AgentsFacility Regulation and ControlRegistriesAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmCarcinoma, Squamous CellCarcinomaDisease ProgressionReverse Transcriptase Polymerase Chain ReactionRisk AssessmentUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungNational Cancer Institute (U.S.)QuestionnairesColorectal NeoplasmsCell Line, TumorGene Expression ProfilingReceptors, EstrogenXenograft Model Antitumor AssaysAge FactorsLong-Term CareTumor Markers, BiologicalNeoplasm StagingMutationSurvivorsOdds RatioRNA, MessengerRisk FactorsReceptor, erbB-2Rectal NeoplasmsNursing HomesNeoplasm Recurrence, LocalCombined Modality TherapyBlotting, WesternMultivariate AnalysisSensitivity and SpecificityNeoplasm TransplantationDisease-Free SurvivalProstate-Specific AntigenDNA, NeoplasmMammographyCell Transformation, NeoplasticEndometrial NeoplasmsSmokingRNA, Small InterferingLogistic ModelsDNA MethylationHealth Services AccessibilityAqueous HumorChemotherapy, AdjuvantMedical OncologyCell SurvivalToilet FacilitiesTumor Suppressor Protein p53Esophageal NeoplasmsFluorouracilMilitary FacilitiesGenotypeTamoxifenTransplantation, HeterologousNeoplastic Stem CellsJapanKaplan-Meier EstimateCisplatinReceptors, ProgesteroneAntineoplastic Agents, PhytogenicOligonucleotide Array Sequence AnalysisReproducibility of ResultsCell MovementGenes, BRCA1Antineoplastic Agents, HormonalDown-RegulationAntigens, NeoplasmSEER ProgramBreastDose-Response Relationship, DrugLiver NeoplasmsIncidenceClinical Trials as TopicAdenocarcinomaTumor BurdenDrug Screening Assays, AntitumorHead and Neck NeoplasmsCancer Care FacilitiesCell DivisionAnticarcinogenic AgentsPredictive Value of TestsNeoplasms, Radiation-InducedMouth NeoplasmsConfidence IntervalsNeoplasms, Hormone-DependentTreatment OutcomePolymorphism, GeneticCell CycleHomes for the AgedMolecular Targeted TherapyCarcinoma, Small CellCross-Sectional StudiesPaclitaxelOccupational ExposurePolymerase Chain ReactionCell ProliferationCell Growth ProcessesApoptosisPromoter Regions, GeneticQuality of LifeAmerican Cancer SocietyBone NeoplasmsReceptor, Epidermal Growth FactorRadiotherapyNeoplasms, Second PrimaryMicroRNAsTransfectionChinaProstateNeoplasms, Glandular and EpithelialRNA InterferenceAntibodies, MonoclonalNeovascularization, PathologicTumor Suppressor ProteinsUp-RegulationModels, BiologicalGene SilencingIntermediate Care FacilitiesSkin NeoplasmsGenes, Tumor SuppressorTumor Cells, CulturedTime FactorsGenital Neoplasms, FemaleDeoxycytidineTrabecular MeshworkGerm-Line MutationPrecancerous ConditionsGenes, NeoplasmNeoplasm GradingMice, SCIDDietTissue Array AnalysisGastrointestinal NeoplasmsAge DistributionPalliative CareAntimetabolites, AntineoplasticQuality of Health CareBase SequenceGenes, p53Receptors, AndrogenAnimals, LaboratoryPostmenopausePrevalenceSocioeconomic FactorsMaternal Health ServicesHealth Facility EnvironmentMolecular Sequence DataTaxoidsHCT116 CellsDrug Administration ScheduleMCF-7 CellsThyroid NeoplasmsRNA, NeoplasmDNA-Binding ProteinsEuropean Continental Ancestry GroupFlow CytometryOccupational DiseasesGene ExpressionImmunoenzyme TechniquesGene Knockdown Techniques

*Columbia Memorial Hospital (Oregon)

Hayes, Elizabeth (May 11, 2015). "As demand for cancer care soars, OHSU expands Astoria facility". Portland Business Journal. ... Services at the facility include a level IV trauma center. Other services include hospice care, cardiac services, imaging, a ... Mary's Hospital, which had been the first such facility in the city when it opened in 1880. At the time of this acquisition, ... In 1975, the hospital started a fundraising drive to provide funds for a new facility to replace the nearly 50-year-old ...

*Government Royapettah Hospital

The centre is the first exclusive government-run facility for cancer care in the state. Terriest city In 2011, as part of its ... "Rs 10cr for cancer unit at Royapettah hospital". The Times of India. Chennai: The Times Group. 17 August 2012. Retrieved 28 Apr ... The cancer treatment centre at the hospital's annexure building was constructed for ₹ 170 million. ... General Hospital Kilpauk Medical College Stanley Medical College Government Hospital of Thoracic Medicine Adyar Cancer ...

*Waycross, Georgia

The three-story facility has a trauma unit, cancer care unit, outpatient surgery and imaging services. In 2012, Satilla ... With over 1,000 employees and 100 physicians, Satilla Regional Medical Center is a leading center in health care in the area. ...

*Max Med Centre Services Lajpat Nagar

Max Institute of Cancer Care Lajpat Nagar is a healthcare facility situated in New Delhi, India. The hospital has Breast Clinic ... External link in ,publisher= (help) Template:Max Institute of Cancer Care-Lajpat Nagar. ... It provides preventive, curative and consultancy services pertaining to areas including Dental Care, Eye Care, Oncology, ... The facility is situated in Lajpat Nagar New Delhi. It is the Authorized Panel Site for Immigration Check for countries ...

*Two-step floating catchment area method

2SFCA can also be used to measure other accessibility such as accessibility to jobs, to cancer care facilities, etc. It was ... Luo, W.; Wang, F. (2003b). "Measures of spatial accessibility to health care in a GIS environment: synthesis and a case study ... In essence, the 2SFCA method measures spatial accessibility as a ratio of primary-care physicians to population, combining two ... Spatial accessibility to primary care and physician shortage area designation: a case study in Illinois with GIS approaches. In ...

*Narayana Health

Bangalore, Mazumdar Shaw Medical Centre: Mazumdar-Shaw Medical Center is a 1400-bed cancer care facility in the NH Health City ... Narayana Health operates a chain of hospitals, heart centres, and primary care facilities across India. Narayana Health ( ... Narayana Health offers speciality and tertiary care facilities covering a wide range of specialisation viz. cardiac surgery, ... and Mazumdar Shaw Medical Centre a multi-speciality hospital for cancer care, neurology and neurosurgery, nephrology and ...

*Nebraska Methodist Health System

There are 685 beds within the system, with facilities offering programs in obstetrics, neurology, cancer care, cardiology, ... The three major facilities in the system, Methodist Jennie Edmundson Hospital (Council Bluffs, Iowa), Methodist Women's ... Two dozen additional facilities in rural Nebraska and Iowa provide family practice services and specialties including ... "Hospitals and health care systems", United Methodist Church. Retrieved 4/12/08. Methodist Health System. Google Finance. ...

*Carl J. Shapiro

27 million to Dana-Farber/Brigham and Women's Cancer Center to substantially upgrade and expand its facilities for cancer care ... for the world's most advanced cardiovascular care facility, the Carl J. and Ruth Shapiro Cardiovascular Center, designed to ...

*Mount Sinai Hospital (Manhattan)

... patient-oriented comprehensive cancer care and research facility. Sander S. Florman, Director of Recanati/Miller Transplant ... James Tisch and wife Merryl Tisch donated $40 million to establish The Tisch Cancer Institute, a state-of-the-art, ... Derald Ruttenberg donated $7 million to establish the Ruttenberg Cancer Center at Mount Sinai and later contributed $8 million ... The center promotes access to medical care and offers support to caregivers needing referrals or education. ...

*St. Mary-Corwin Medical Center

Mary-Corwin Medical Center is a full service, 408-bed facility specializing in orthopedics, cancer care, emergency services, ... Mary-Corwin is a modern medical facility with its own Flight For Life base, comprehensive cancer center, residency program and ... "Pueblo CO Medical Specialties - Emergency, Cancer Care". www.stmarycorwin.org. Retrieved 9 June 2017. [1][dead link] "Patient ... breast care and women's services. St. Mary-Corwin Medical Center's history of caring for the people of southern Colorado began ...

*Shayne Corson

... has been a prominent proponent of building a cancer care facility, the Simcoe-Muskoka Regional Cancer Centre, as part of ... from throat cancer in 1993. Corson's sister, Shannon, is married to former Toronto Maple Leaf teammate Darcy Tucker. In ...

*James S. Tisch

... patient-oriented comprehensive cancer care and research facility at the Mount Sinai Hospital, New York. Tisch was a supporter ... James and wife Merryl donated $40 million to establish The Tisch Cancer Institute, a state-of-the-art, ...

*Raghu Ram Pillarisetti

... mother who had been diagnosed with breast cancer and decided to open a dedicated purpose built facility for breast cancer care ... "Breast Cancer India". Breast Cancer India. 2015. Retrieved March 8, 2015. "My Global Hospital". My Global Hospital. 2015. ... "Ushalakshmi Breast Cancer Foundation". Ushalakshmi Breast Cancer Foundation. 2015. Retrieved March 8, 2015. "Indian Express". ... He is also the founder of Ushalakshmi Breast Cancer Foundation, a private organization working in tandem with government and ...

*Charles Juravinski

... permitting the establishment of a new state-of-the-art cancer care facility at the former Henderson Hospital, now renamed ... of the Juravinski Hospital and Juravinski Cancer Centre in Hamilton, Ontario. Charles Juravinski was born in Saskatchewan, and ...

*List of MeSH codes (N02)

... cancer care facilities MeSH N02.278.421.556.110 --- cardiac care facilities MeSH N02.278.421.556.185 --- hospices MeSH N02.278. ... intermediate care facilities MeSH N02.278.825.610.770 --- skilled nursing facilities MeSH N02.278.825.700 --- orphanages MeSH ... dental care MeSH N02.421.240.190.210 --- dental care for aged MeSH N02.421.240.190.215 --- dental care for children MeSH ... custodial care MeSH N02.421.585.246 --- day care MeSH N02.421.585.300 --- episode of care MeSH N02.421.585.352 --- foster home ...

*Jacobs Medical Center

The Pauline and Stanley Foster Pavilion for Cancer Care is a 108-bed facility affiliated with Moores Cancer Center and ... The facility, which offers specialized care not previously available in San Diego County, opened on November 20, 2016. Jacobs ... Floors four through six are reserved for the Pauline and Stanley Foster Pavilion for Cancer Care, and the eighth through tenth ... The pavilion includes a Level III Neonatal Intensive Care Unit to monitor and care for severely premature or ill infants. ...

*Cotabato Regional and Medical Center

... health facility enhancement was accomplished by the construction of Oxygen Generating Plant and the DILANGALEN Cancer Care ... 60-B, s.1973 upgrading Cotabato Hospital to a 200 bed capacity facility and accredited it as a Tertiary, Teaching, and Training ... With the AO 2012-0012 dated July 18, 2012 DOH new classification of hospitals and other health facilities in the Philippines, ... In 1994, due to increasing demands in health services, the CRMC underwent health facility improvement with the construction of ...

*Fox Chase Cancer Center

Fox Chase's 100-bed hospital is one of the few facilities in the country devoted entirely to cancer care. Annual hospital ... Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital ... As of 2014, the Fox Chase Cancer Center was ranked as the 19th best cancer hospital in the United States by U.S. News & World ... "anti-cancer vaccine", which has reduced the incidence of liver cancer. 1975 The first transgenic mammals containing foreign DNA ...

*Beatson West of Scotland Cancer Centre

... is a specialised cancer care centre in Glasgow, Scotland. Until recently it had facilities in Gartnavel General Hospital, the ... A domiciliary nursing service was set up at the same time to care for cancer patients in their own homes. In 1896, new premises ... In 1912, HRH Princess Louise, Duchess of Argyll, opened the rebuilt facilities which were named the Royal Glasgow Cancer ... The BWSCC is the lead centre for delivery of non-surgical cancer care for the West of Scotland, serving a population of 2.8 ...

*University of Pittsburgh Cancer Institute

UPCI works in tandem with UPMC Cancer Centers to provide clinical cancer care to some 74,000 patients treated at its facilities ... breast cancer, colon and gastrointestinal cancers, head and neck cancers, leukemias and lymphomas, liver cancer, lung cancer, ... The University of Pittsburgh Cancer Institute (UPCI) is a National Cancer Institute (NCI)-designated Comprehensive Cancer ... skin care products and prostheses. In 2012, the Hillman Cancer Center opened the Mario Lemieux Center for Blood Cancers on the ...

*Alberta Health Services

AHS maintains and runs a number of different types of facilities and services. These include: Cancer Care For the prevention, ... education and care of cancer patients, as well as to facilitate research of cancer. Continuing and Long-Term Care For the ... continuing care facilities, mental health facilities and community health sites, while providing a variety of programs and ... They also fund affordable housing for seniors at facilities, such as Silvera for Seniors. Urgent Care To treat patients with ...

*Novant Health

... as well as additional facilities from Novant Health including assisted living, outpatient cancer care, and ambulatory physician ... To qualify for the full Level II designation, the hospital must care for 1,200 trauma patients in the year following the ... In 2014, Novant Health provided more than $639 million in community benefit, including charity care and services.[citation ... Jude Affiliate Clinic at Novant Health Hemby Children's Hospital provides specialized hematology and oncology care for ...

*Gartnavel General Hospital

... with the most recent being a new cancer care centre to replace the current Beatson Oncology Centre facilities that are ... "Work begins on £87m cancer centre". BBC News. 7 July 2004. Retrieved 2006-11-29. "About Us". Beatson Oncology Centre. Archived ...

*Tomball, Texas

It is a full-service 357-bed facility hospital providing special expertise in cardiovascular disease, cancer care, emergency ... services, digital diagnostic imaging, physical rehabilitation, sports medicine, and comprehensive wound and lymphedema care. ...

*James D. Bearden III

The Gibbs Cancer Center & Research Institute is a state-of-the-art facility with advanced diagnostic and treatment tools and a ... Bearden has devoted his medical career to providing the finest cancer care to patients throughout South Carolina. He has helped ... In addition, Bearden has served as the principal investigator of the National Cancer Institute Community Cancer Center Program ... bring facilities, scientists and physicians to care for patients in medically underserved communities throughout the state. He ...

*Helen F. Holt

In her role as special assistant, Holt helped to reform long-term care facilities and provided insured mortgages to build more ... She remained married to him until his death from cancer on February 8, 1955. At the time of his death, Rush was serving in the ... Following Rush's death from cancer in 1955, Helen was appointed by Governor William C. Marland to fill Rush's seat in the West ...
BRCA breast cancer Archives - - UNM Comprehensive Cancer Center - UNM Comprehensive Cancer Center  BRCA breast cancer Archives - - UNM Comprehensive Cancer Center - UNM Comprehensive Cancer Center
The UNM Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Comprehensive Cancer Center in the state.
http://cancer.unm.edu/tag/brca-breast-cancer/
BRCA mutation Archives - - UNM Comprehensive Cancer Center - UNM Comprehensive Cancer Center  BRCA mutation Archives - - UNM Comprehensive Cancer Center - UNM Comprehensive Cancer Center
The UNM Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Comprehensive Cancer Center in the state.
http://cancer.unm.edu/tag/brca-mutation/
NCCN Guidelines Insights: Non-Hodgkins Lymphomas, Version 3.2016 in: Journal of the National Comprehensive Cancer Network...  NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016 in: Journal of the National Comprehensive Cancer Network...
1 From Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Womens Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores ...
https://jnccn.org/abstract/journals/jnccn/14/9/article-p1067.xml?rskey=pjhvfi&result=8
Fox Chase Cancer Center - Wikipedia  Fox Chase Cancer Center - Wikipedia
Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital located in the Fox Chase section of Philadelphia, Pennsylvania, United States. The main facilities of the center are located on property adjoining Burholme Park. The center is part of the Temple University Health System (TUHS) and specializes in the treatment and prevention of cancer. The center was formed in 1974 by the merger of the American Oncologic Hospital, which was founded in 1904 as the first cancer hospital in the United States, and the Institute for Cancer Research, founded in 1927. The center was an independent, non-profit institution until it became part of TUHS July 1, 2012. Today it has almost 2,400 employees and an operating budget of $300 million. Research is conducted in more than 80 laboratories by a staff of more than 325 physicians and scientists who hold medical degrees, Ph.D.s or both. Fox Chases 100-bed hospital is one of the few facilities in the ...
https://en.wikipedia.org/wiki/Fox_Chase_Cancer_Center
Moffitt Cancer Center and Leukemia & Lymphoma Society® Offer Free Educational Event on Treatment and Research Advances for...  Moffitt Cancer Center and Leukemia & Lymphoma Society® Offer Free Educational Event on Treatment and Research Advances for...
WHO: Moffitt Cancer Center, the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, will host Lymphoma Treatment Today and the Research Outlook for Tomorrow, a free educational event in collaboration with the Leukemia & Lymphoma Society®.. WHAT: The free educational event will feature Moffitt experts discussing the latest recommendations for treatment and promising research outlooks for Lymphoma. Attendees will have an opportunity ask questions during several breakout sessions.. WHEN: Thursday, Jan. 16, 2014, 4:30 - 8:30 p.m.. WHERE: Moffitt Cancer Center, 12902 Magnolia Drive, Stabile Research Building, Tampa, Fla. 33612. CONTACT: Pre-registration is required. Please call 813-963-6461, ext. 1798.. About Moffitt Cancer Center. Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitts excellence in research, its contributions to clinical trials, prevention and cancer ...
https://moffitt.org/newsroom/press-release-archive/2013/moffitt-cancer-center-and-leukemia-lymphoma-society-offer-free-educational-event-on-treatment-and-research-advances-for-lymphoma/
Powerhouse medical oncologist joins UAB as director of the UAB Comprehensive Cancer Center | UAB Comprehensive Cancer Center  Powerhouse medical oncologist joins UAB as director of the UAB Comprehensive Cancer Center | UAB Comprehensive Cancer Center
Birrer comes to UAB from Massachusetts General Hospital, where he is director of Medical Gynecologic Oncology and director of the Gynecologic Cancer Research Program at the Gillette Cancer Center. He also serves as the leader of the Dana Farber/Harvard Cancer Center program in gynecologic cancers and is a professor of medicine at Harvard Medical School.. Birrer will succeed Edward E. Partridge, M.D., the Evalina B. Spencer Chair in Oncology, who is retiring from UAB after a remarkable 48-year career, including 10 years as director of the Comprehensive Cancer Center. Birrer will join UAB on Aug. 1.. "Mike Birrer is an outstanding physician-scientist who balances a vision of transformation and leadership," said Selwyn M. Vickers, M.D., FACS, senior vice president for Medicine and dean of the School of Medicine. "He understands drivers for excellence in clinical care and has a vision for growing precision medicine in cancer care, as well as a well-established commitment to fundamental scientific ...
http://www3.ccc.uab.edu/newsroom/powerhouse-medical-oncologist-joins-uab-as-director-of-the-uab-comprehensive-cancer-center/
About the University of Michigan Comprehensive Cancer Center | University of Michigan Comprehensive Cancer Center  About the University of Michigan Comprehensive Cancer Center | University of Michigan Comprehensive Cancer Center
Get cancer facts, patient care numbers, updates on cancer clinical care, cancer support services, cancer research programs and learn about our community outreach efforts - as well as meet the U-M Comprehensive Cancer Center leadership.
https://www.mcancer.org/about
Leadership - University of Chicago Medicine Comprehensive Cancer Center  Leadership - University of Chicago Medicine Comprehensive Cancer Center
Michelle M. Le Beau, PhD, Arthur and Marian Edelstein Professor of Medicine, was appointed director of the University of Chicago Medicine Comprehensive Cancer Center in April 2004. Dr. Le Beau is particularly well qualified to enhance translational and interdisciplinary research at the Comprehensive Cancer Center, in view of her impressive record of converting fundamental laboratory findings into highly relevant advances in the diagnosis and treatment of patients with hematological malignant diseases.. Dr. Le Beau received her PhD in pathology and genetics in 1981 at the University of Illinois. She subsequently obtained post-doctoral training at The University of Chicago Medicine under the mentorship of Janet D. Rowley, MD, DSc, the Blum-Riese Distinguished Service Professor of Medicine, and was appointed to the faculty in 1986, rising to tenured professor in 1997. In her capacity as director of the Cancer Cytogenetics Laboratory, Dr. Le Beau directs a cancer diagnostics laboratory, which ...
http://cancer.uchicago.edu/about/leadership/
Chiung-Yu Huang, PhD | UCSF Helen Diller Family Comprehensive Cancer Center  Chiung-Yu Huang, PhD | UCSF Helen Diller Family Comprehensive Cancer Center
Dr. Chiung-Yu Huang is Professor of Biostatistics at the Department of Epidemiology and Biostatistics and an elected Fellow of the American Statistical Association (ASA). She is a Member of the UCSF Helen Diller Family Comprehensive Cancer Center and an Adjunct Professor at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center. She is recognized for her novel methodology research in survival analysis, competing risks analysis, recurrent event analysis, outcome-dependent sampling, and design and evaluation of vaccine efficacy trials. Dr. Huangs recent methodology contributions include (1) methods for combining information from external large databases, such as disease registries, to improve efficiency in the analysis of relatively small-scale studies that collect more detailed patient-level information. The importance of such methods has been recognized as we have now entered the big bata era; (2) methods to better model, estimate, and predict the risk of recurrent events to ...
https://cancer.ucsf.edu/people/profiles/huang_chiungyu.8706
SBL Regional Cancer Center Offers Innovative Treatment for Prostate Cancer | Sarah Bush Lincoln  SBL Regional Cancer Center Offers Innovative Treatment for Prostate Cancer | Sarah Bush Lincoln
Men with advanced prostate cancer can now receive a new innovative treatment in the Sarah Bush Lincoln Regional Cancer Center. SBL is the only cancer center in the region to offer Xofigo® , a new type of targeted radiation therapy.. In May, the U.S. Food and Drug Administration (FDA) approved Xofigo® (radium 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones, but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone.. "Xofigo® is an important new treatment added to our robust nuclear therapeutics program," said Abdur R Shakir, MD, SBL Regional Cancer Center Medical Director. "While we provide the people of East Central Illinois with leading-edge treatments for a broad range of cancers, we are proud to play a significant role in the development and delivery of important new breakthrough treatments as part of the Regional Cancer ...
https://www.sarahbush.org/news/all/2013/oct/sbl-regional-cancer-center-offers-innovative-treat/
UAB and Nations Cancer Centers Jointly Endorse Updated HPV Vaccine Recommendations | UAB Comprehensive Cancer Center  UAB and Nation's Cancer Centers Jointly Endorse Updated HPV Vaccine Recommendations | UAB Comprehensive Cancer Center
Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), the UAB Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).. According to the CDC, incidence rates of HPV-associated cancers have continued to rise, with approximately 39,000 new HPV-associated cancers now diagnosed each year in the United States. Although HPV vaccines can prevent the majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers, vaccination rates remain low across the U.S., with just 41.9 percent of girls and 28.1 percent of boys completing the recommend vaccine series.. The new guidelines from the CDC recommend that children aged 11 to 12 should receive two doses of the HPV vaccine at least six months apart. Adolescents and young adults older than 15 ...
http://www3.ccc.uab.edu/newsroom/uab-and-nations-cancer-centers-jointly-endorse-updated-hpv-vaccine-recommendations/
Comprehensive Cancer Center inspires staff: UC Davis Health System Feature Story  Comprehensive Cancer Center inspires staff: UC Davis Health System Feature Story
Marnie Livingston, Tammy Welden and Abbey DeGraffenreid. Posted May 8, 2013. Marnie Livingston is grateful that her breast cancer was caught early and treated successfully. Tammy Welden is appreciative for her sons renewed health after an accident left him near death. Abbey DeGraffenreid is thankful that she no longer has signs of lymphoma. And Terri Wolf is glad for her secure job as an oncology nurse.. They are among a growing number of UC Davis Health System employees who invest in community health by supporting the UC Davis Comprehensive Cancer Center.. Livingston, an executive assistant, is donating $5,000 to the cancer centers expansion project to honor her surgical oncologist, James Goodnight.. "I am donating because I want to make sure that other people can get the kind of care that I received," says Livingston.. Abbey DeGraffenreid, who works in perioperative services, is donating $5,000 to honor Goodnight, $2,500 to name an infusion chair and $2,500 to lymphoma research.. "I hope to ...
http://www.ucdmc.ucdavis.edu/welcome/features/2012-2013/05/20130508_AR_ccc_inspires_staff.html
Pancreatic Cancer Patient Education | Pancreatic Cancer Center | Ann Arbor | University of Michigan Comprehensive Cancer Center  Pancreatic Cancer Patient Education | Pancreatic Cancer Center | Ann Arbor | University of Michigan Comprehensive Cancer Center
A listing of the available patient education materials covering pancreatic cancer, pancreatic cysts and other diseases of the pancreas developed by the Pancreatic Cancer Clinic at the University of Michigan Comprehensive Cancer Center.
https://www.mcancer.org/pancreatic-cancer/patient-education
Administration & Staff - UNC Lineberger Comprehensive Cancer Center  Administration & Staff - UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Centers leadership, program directors, communications and development staff, and N.C. Cancer Hospital administration
https://unclineberger.org/waystohelp/about/admin
Holden Comprehensive Cancer Center | Mesothelioma Cancer Centers  Holden Comprehensive Cancer Center | Mesothelioma Cancer Centers
The Holden Comprehensive Cancer Center at the University of Iowa Hospitals & Clinics in Iowa City, Iowa is home to a lung cancer clinic where mesothelioma and other lung diseases are treated.
http://mesotheliomago.com/treatment/cancer-centers/holden-comprehensive-cancer-center.html
UC Davis Comprehensive Cancer Center marks Lung Cancer Awareness Month  UC Davis Comprehensive Cancer Center marks Lung Cancer Awareness Month
The UC Davis Comprehensive Cancer Center will host a Tweet chat to discuss the latest approaches to lung cancer treatment on Nov. 27 at 1 p.m. in recognition of Lung Cancer Awareness Month. Twitter users are invited to log in and join the conversation about new medical, surgical and radiation oncology approaches to the disease from cancer center experts. To join, follow #UCDcancerchat.
http://www.ucdmc.ucdavis.edu/publish/news/surgery/7210
Cancer Center Membership - University of Chicago Medicine Comprehensive Cancer Center  Cancer Center Membership - University of Chicago Medicine Comprehensive Cancer Center
The mission of the Comprehensive Cancer Center is "to elucidate the determinants of cancer, to develop cures for cancer and to prevent cancer through innovation and collaboration.". Members are expected to contribute to this overriding objective through a broad range of clinical and research activities including:. ...
https://cancer.uchicago.edu/research/membership/
The Robert H. Lurie Comprehensive Cancer Center - Steven Rosen  The Robert H. Lurie Comprehensive Cancer Center - Steven Rosen
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University is an NCI-designated, university based, matrix cancer center conducting a broad range...
http://grantome.com/grant/NIH/P30-CA060553-19
European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence - Progetto di formazione e...  European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence - Progetto di formazione e...
The expansion of knowledge in the area of cancer biology which has taken place over the last 40 years has profoundly influenced clinical cancer research and made high-quality multidisciplinary cancer care imperative. In the United States, Comprehensive Cancer Centres (CCCs) have existed for a long time. To enhance their effectiveness and quality, the National Cancer Institute (NCI) has developed an accreditation methodology for CCCs [1]. NCI-designated CCCs are characterised by innovative high-quality cancer research covering the complete trajectory-from basic to clinical research, as well as dissemination of acquired knowledge.. ...
http://progetto-odin.it/european-academy-of-cancer-sciences-designation-of-comprehensive-cancer-centres-of-excellence/
Core Facilities Training Program | Roswell Park Comprehensive Cancer Center  Core Facilities Training Program | Roswell Park Comprehensive Cancer Center
This training program is available to allied health care professionals and medical staff. It provides candidates with the appropriate training to fully operate a functional scientific oncology core facility at their home institution or hospital. The training will be provided at Roswell Park Comprehensive Cancer Center under the supervision of a core director and appropriate Roswell Park staff.
https://www.roswellpark.org/education/oico/oico-training-programs/core-facilities-training
Histology Facility | Roswell Park Comprehensive Cancer Center  Histology Facility | Roswell Park Comprehensive Cancer Center
The Histology Facility (HF) is a centralized lab that provides tissue processing and histology services for research studies at Roswell Park Comprehensive Cancer Center.
https://www.roswellpark.org/shared-resources/pathology-network/services-and-fees/histology-facility
UCLAs Jonsson Comprehensive Cancer Center  UCLA's Jonsson Comprehensive Cancer Center
UCLA scientists have unlocked an important mechanism that allows chemotherapy-carrying nanoparticles-extremely small objects between 1 and 100 nanometers (a billionth of a meter)-to directly access pancreatic cancer tumors, thereby improving the ability to kill cancer cells and hence leading to more effective treatment outcome of the disease. The researchers also confirmed the key role of a peptide (an extremely small protein) in regulating vascular access of the nanoparticle to the cancer site.. The discovery is the result of a two-year study co-led by Drs. Huan Meng and André Nel, members of UCLAs Jonsson Comprehensive Cancer Center and the UCLA California NanoSystems Institute. The findings are important as they demonstrate how the delivery of chemotherapy to pancreatic cancer can be improved significantly through the use of smart-designed nanoparticle features.. Pancreatic ductal adenocarcinoma is generally a fatal disease, with a five-year survival rate of less than 6 percent. The ...
http://nanocomputer.com/?tag=uclas-jonsson-comprehensive-cancer-center
Boggess Awarded Triangle Business Journals Health Care Heroes Award - UNC Lineberger Comprehensive Cancer Center  Boggess Awarded Triangle Business Journal's Health Care Heroes Award - UNC Lineberger Comprehensive Cancer Center
CHAPEL HILL, N.C. - John Boggess, MD, associate professor of obstetrics and gynecology, was honored with a Health Care Heroes Award by the Triangle Business Journal. His Health Care Innovator/Researcher Award was given in recognition of his pioneering work with robotic surgery for gynecologic cancers. Boggess is a member of UNC Lineberger Comprehensive Cancer Center.. Due in large part to his training of other surgeons, robotic surgery is now the number one treatment for gynecologic cancer in the US, according to an executive with Intuitive Surgical, Inc. Boggess has presented the surgical techniques at national and international meetings and has hosted training visits to UNC for over 400 gynecologic oncology specialists.. The greatest significance of Boggess efforts is the impact robotic-assisted surgery has for patients. He has published reports in professional journals demonstrating that robotic-assisted surgery decreases complications, blood loss, pain and recovery time without compromising ...
http://unclineberger.org/news/2011-news/health-care-heroes-award
Find a Clinical Trial | Page 3 | Herbert Irving Comprehensive Cancer Center  Find a Clinical Trial | Page 3 | Herbert Irving Comprehensive Cancer Center
The Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian / Columbia University Irving Medical Center is conducting hundreds of clinical trials to improve care for many types of conditions.. Use the tool below to find our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, links to the investigators biography, the trials eligibility criteria, and how to get more information.. ...
http://cancer.columbia.edu/clinical-trials?title=&term_node_tid_depth=436&page=2
Find a Clinical Trial | Herbert Irving Comprehensive Cancer Center  Find a Clinical Trial | Herbert Irving Comprehensive Cancer Center
The Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian / Columbia University Irving Medical Center is conducting hundreds of clinical trials to improve care for many types of conditions.. Use the tool below to find our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, links to the investigators biography, the trials eligibility criteria, and how to get more information.. ...
http://cancer.columbia.edu/clinical-trials/node/
Centers of Excellence in Research - Comprehensive Cancer Center - Wake Forest School of Medicine  Centers of Excellence in Research - Comprehensive Cancer Center - Wake Forest School of Medicine
The Comprehensive Cancer Center of Wake Forest University has selected three types of cancer on which to focus major research efforts and expertise: brain tumors, breast cancer, and prostate cancer.
http://www.wakehealth.edu/Research/Comprehensive-Cancer-Center/Centers-of-Excellence.htm
UCLA Jonsson Comprehensive Cancer Center : Prostate Cancer  UCLA Jonsson Comprehensive Cancer Center : Prostate Cancer
UCLAs Jonsson Comprehensive Cancer Center. Get information on prostate cancer risk factors, prevention, symptoms, diagnosis, treatment and more.
https://cancer.ucla.edu/patient-care/understanding-cancer/cancer-types-101/prostate-cancer
News & Events - Sylvester Comprehensive Cancer Center  News & Events - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center is South Floridas leader in cancer diagnosis and provides state-of-the-art treatment as well as follow-up care.
http://sylvester.org/news/
2013 - News & Events - Sylvester Comprehensive Cancer Center  2013 - News & Events - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center is South Floridas leader in cancer diagnosis and provides state-of-the-art treatment as well as follow-up care.
http://sylvester.org/news/2013/02
For Smokers, UCSF Program Provides Tools to Ditch the Habit | UCSF Helen Diller Family Comprehensive Cancer Center  For Smokers, UCSF Program Provides Tools to Ditch the Habit | UCSF Helen Diller Family Comprehensive Cancer Center
While tobacco use is the single largest preventable cause of disease and premature death in the United States, smoking has become far less prevalent in the country in recent years, in part because of anti-tobacco campaigns and a general push toward better health, says Stanton A. Glantz, PhD, director of the Center for Tobacco Control Research and Education. The centers faculty members are affiliated with the UCSF Helen Diller Family Comprehensive Cancer Center.. "Currently, in California, about 12 percent of the population smokes, Glantz says, "with two-thirds of them being light smokers.. For social smokers as well as heavy smokers, it can be a daunting challenge to halt an entrenched addiction. Some are afraid to stop - theyve smoked so long. Some are ashamed to reach out for help until theyre sick. And some simply believe they can quit whenever they like.. At their disposal awaits a battery of possible remedies: nicotine replacement patches and gum, nicotine inhalers, antidepressants, ...
http://cancer.ucsf.edu/news/2012/07/27/for-smokers-ucsf-program-provides-tools-to-ditch-the-habit.3989
The University of Chicago Comprehensive Cancer Center, Chicago | Mesothelioma.net  The University of Chicago Comprehensive Cancer Center, Chicago | Mesothelioma.net
At the University of Chicago Comprehensive Cancer Center patients can benefit from the experience of staff for excellent mesothelioma care.
https://mesothelioma.net/university-chicago-comprehensive-cancer-center/
Cédric Cleyrat, PhD - - UNM Comprehensive Cancer Center - UNM Comprehensive Cancer Center  Cédric Cleyrat, PhD - - UNM Comprehensive Cancer Center - UNM Comprehensive Cancer Center
My research interests are focused on understanding how protein interactions and trafficking events, within the overall cell architecture, are related to pathogenic mechanisms in cancer. During the past few years, I have been able to build on my solid background in molecular and cellular biology by acquiring skills in state-of-the-art biochemical and imaging techniques. One of my two main scientific foci is on the high affinity receptor for IgE, the FcεRI, and its implication in allergies, asthma and mast cell diseases. I am applying my unique skill set to the dissection of FcεRI signal initiation and the spatiotemporal coordination of endocytic trafficking by signaling and adaptor proteins. My second area of research aims at uncovering the underlying mechanisms of the myeloproliferative neoplasms (MPNs) pathogenesis. I am characterizing the complex interplay between Jak2, Mpl and calreticulin, the three main players in MPNs, and their altered trafficking-related signaling properties. My ...
http://cancer.unm.edu/member/ccleyrat/
Liver Cancer | UC Davis Comprehensive Cancer Center  Liver Cancer | UC Davis Comprehensive Cancer Center
Liver cancer information: signs and symptoms, diagnosis, treatment, your team, and support from UC Davis Comprehensive Cancer Center.
https://health.ucdavis.edu/cancer/cancer-types/liver.html
UCLA Jonsson Comprehensive Cancer Center : List View  UCLA Jonsson Comprehensive Cancer Center : List View
2018 UCLA Jonsson Comprehensive Cancer Center. All Rights Reserved. , Website Created By Vision Internet - Innovators of Online Government. ...
https://cancer.ucla.edu/Home/Components/Calendar/Event/2268/1632?backlist=%2Fresearch%2Factive-clinical-trials%2Fclinical-trials-education
Conditions - Mat-Su Valley Comprehensive Cancer Center  Conditions - Mat-Su Valley Comprehensive Cancer Center
Mat-Su Valley Comprehensive Cancer Center Is Your Provider For Treatment & Relief From Cancer In & Around Palmer, AK. Call Us Today To Start Your Fight!
http://www.matsuvalleycancer.com/conditions/
UAB - School of Medicine - News - News - Students  UAB - School of Medicine - News - News - Students
The UAB Comprehensive Cancer Center has received a prominent national Innovator Award from the Association of Community Cancer Centers (ACCC) for its Patient Care Connect Program. The award is given only to ACCC members that are forward-thinking in creating replicable solutions to improve access, quality and value of patient care ...
http://www.uab.edu/medicine/news/events/itemlist/tag/patient%20care?limitstart=0
UAB - School of Medicine - News - News - Students  UAB - School of Medicine - News - News - Students
The UAB Comprehensive Cancer Center has received a prominent national Innovator Award from the Association of Community Cancer Centers (ACCC) for its Patient Care Connect Program. The award is given only to ACCC members that are forward-thinking in creating replicable solutions to improve access, quality and value of patient care ...
http://www.uab.edu/medicine/news/events/itemlist/tag/patient%20care
Institute for Clinical Immuno-Oncology Aims to Advance Access to Therapies in Community Setting - http://cyto.blogs.sapo.pt  Institute for Clinical Immuno-Oncology Aims to Advance Access to Therapies in Community Setting - http://cyto.blogs.sapo.pt
The Association of Community Cancer Centers (ACCC) has launched the Institute for Clinical Immuno-Oncology (ICLIO) in order to promote the advancement of access to immuno-oncology therapies, particularly in the community care setting.. To facilitate the adoption of immuno-oncology in the community cancer setting, ICLIO will educate medical professionals on the best practices for integrating immuno-oncology into clinical care, insurance and reimbursement, social work, and patient access to novel treatment options.. Resources for the multidisciplinary team include a monthly e-newsletter, monthly e-courses, the ICLIO Scholars Program, the ICLIO White Paper, and the ICLIO National Education Conference.. RELATED: Immunotherapies Shine at ASCO Annual Meeting. Providers with membership to ACCC, who are estimated to treat over 60% of all patients with cancer, will also have access to ICLIO. ICLIO is chaired by Lee S. Schwartzberg, MD, FACP, Chief of the Division of Hematology and Oncology at The West ...
http://cyto.blogs.sapo.pt/institute-for-clinical-immuno-oncology-127262
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of...  Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of...
Authors Affiliations: 1Complutense University and Hospital General Universitario Gregorio Maranon, Servicio De Oncologia Medica, Madrid, Spain; 2Andrew Love Cancer Centre, Barwon Health, Geelong, Victoria, Australia; 3Clinique Victor Hugo-Centre Jean Bernard, Cedex 2, France; 4University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 5Onkologische Schwerpunktpraxis, Mannheim, Germany; 6Institutul Oncologic Ion Chiricuta, Cluj-Napoca, Romania; 7Cancer Research UK, University of Sussex, Falmer, Brighton, United Kingdom; 8National Cancer Center Hospital, Tokyo, Japan; 9Medical University of Gdansk, Gdańsk, Poland; 10Tom Baker Cancer Centre, Calgary, Alberta, Canada; 11Beatson Oncology Centre, Glasgow, Scotland, United Kingdom; 12Allgemeines Krankenhaus St. Georg, Clinical Division of Oncology, Waehringer Guertel, Vienna, Austria; 13Arizona Cancer Center, University of Arizona, Tucson, Arizona; 14Sylvester Comprehensive Cancer Center at Deerfield, Deerfield Beach, Florida; and Departments ...
http://clincancerres.aacrjournals.org/content/18/17/4841.figures-only
Cancer Program Selected as 1 of 7 National Testing Sites to Address Disparities Faced by Medicaid Patients with Lung Cancer |...  Cancer Program Selected as 1 of 7 National Testing Sites to Address Disparities Faced by Medicaid Patients with Lung Cancer |...
DAYTONA BEACH, Fla., July 25, 2017 - Florida Hospital Memorial Medical Center has been designated as one of seven national testing sites for the Association of Community Cancer Centers (ACCC) project to improve care for Medicaid patients with lung cancer.
https://www.floridahospital.com/news/cancer-program-selected-1-7-national-testing-sites-address-disparities-faced-medicaid-patients
UPMC Announces $2B Investment to Build 3 Digitally Based Specialty Hospitals Backed by World-Leading Innovative, Translational...  UPMC Announces $2B Investment to Build 3 Digitally Based Specialty Hospitals Backed by World-Leading Innovative, Translational...
The UPMC Vision and Rehabilitation Hospital, on the UPMC Mercy campus, is expected to open in 2020 to offer advanced clinical vision care. Clinicians and researchers at the new hospital will pursue promising new research for vision restoration and diseases of the eye, and offer technology-assisted rehabilitation services that restore mobility for patients with wide-ranging physical and cognitive challenges.The all-new hospitals will be situated on the campuses of UPMCs Mercy, Presbyterian and Shadyside hospitals. Designs for the UPMC Heart and Transplant Hospital and the UPMC Hillman Cancer Hospital will be selected in an international design competition.. Patients of the UPMC Hillman Cancer Center, a name that is synonymous with unmatched excellence in cancer care, and the only National Cancer Institute-designated Comprehensive Cancer Center in the region, will receive specialized treatment in the new UPMC Hillman Cancer Hospital, located on the UPMC Shadyside campus. The facility is expected ...
http://news.upmcphysicianresources.com/2017/11/03/upmc-announces-2b-investment-to-build-3-digitally-based-specialty-hospitals-backed-by-world-leading-innovative-translational-science/
Treatment combination improves survival among stage 4 lung cancer patients  Treatment combination improves survival among stage 4 lung cancer patients
Dr. Timmerman, holder of the Effie Marie Cain Distinguished Chair in Cancer Therapy Research, is a member of UT Southwesterns Harold C. Simmons Comprehensive Cancer Center, the only National Cancer Institute-designated cancer center in North Texas and a National Clinical Trials Network Lead Academic Site.. This Phase 2 clinical trial involved 24 patients with stage 4 non-small cell lung cancer (NSCLC) whose cancer has continued to spread during their initial therapy. Such patients typically have poor survival rates, and SBRT is not typically used in these patients, said first author Dr. Puneeth Iyengar, Assistant Professor and Director of Clinical Research of Radiation Oncology, and co-leader of the Simmons Cancer Center Thoracic Oncology Group.. The revolutionary SBRT technique is a type of radiation therapy in which a few very high doses of radiation are delivered from multiple angles to small, well-defined tumors. The goal is to deliver a radiation dose high enough to kill the cancer, while ...
http://oncologynews.com.au/treatment-combination-improves-survival-among-stage-4-lung-cancer-patients/
Department Of Radiotherapy, Regional Cancer Centre, India | ESMO  Department Of Radiotherapy, Regional Cancer Centre, India | ESMO
Department Of Radiotherapy, Regional Cancer Centre, Pgimer, Chandigarh is an ESMO Designated Centre of Integrated Oncology and Palliative Care
http://www.esmo.org/Topics/Palliative-and-supportive-care/Department-Of-Radiotherapy-Regional-Cancer-Centre-Pgimer-Chandigarh-India
JIPMER Regional Cancer Centre to hold awareness camps | Health News  JIPMER Regional Cancer Centre to hold awareness camps | Health News
Regional Cancer Centre (RCC) of the centrally funded premier medical institution JIPMER planned to hold camps in villages to create awareness on various methods for early detection of cancer.
http://zeenews.india.com/news/health/health-news/jipmer-regional-cancer-centre-to-hold-awareness-camps_15985.html
Judith C. Gasson | Department of Biological Chemistry, UCLA  Judith C. Gasson | Department of Biological Chemistry, UCLA
Judith Gasson, Ph.D., became the director of UCLAs Jonsson Comprehensive Cancer Center (JCCC) on Sept. 15, 1995. She is a molecular biologist and is responsible for one of only 40 institutions designated as comprehensive cancer centers by the National Cancer Institute. Gasson earned her doctorate degree in physiology at the University of Colorado in 1979. She did her postdoctoral work at the Salk Institute in La Jolla, CA, studying glucocorticoid hormones, which are made by the adrenal gland in response to stress. In 1983, she left the Salk Institute to join JCCC. Gasson was instrumental in purifying for the first time a hormone-like substance that increases the speed of bone marrow cell reproduction. That substance, called GM-CSF, is used to help prevent infections in cancer patients and to allow those patients to tolerate more chemotherapy and radiation than had previously been possible. For the past fifteen years, Dr. Gasson has been the director of UCLAs Jonsson Comprehensive Cancer Center ...
http://www.biolchem.ucla.edu/node/119
Cancer Program  Cancer Program
Many important changes take place when a doctor tells someone they have cancer. These changes affect the entire circle of family and friends who surround the cancer patient. The goal of the cancer program at Community Memorial Hospital is to provide high quality services to both the patient and their family. Our greatest asset is the compassionate, personalized care afforded our cancer patients.. Since 2006, our cancer program has demonstrated continued success in the diagnosis and treatment of cancer in our community. The American College of Surgeons Commission on Cancer first recognized the excellence of our program when the Commission on Cancer awarded Community Memorial Hospital with the CoC New Program Outstanding Cancer Program Achievement Award in 2008 and has since achieved accreditation in 2011 and 2014. The hospital also received commendations in eight areas:. ...
http://www.cmhshealth.org/services/cancer-program/
HealthNewsDigest.com  HealthNewsDigest.com
UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 10,000 adults and children every year, and access to more than 150 clinical trials at any given time. Its innovative research program engages more than 280 scientists at UC Davis, Lawrence Livermore National Laboratory and Jackson Laboratory (JAX West), whose scientific partnerships advance discovery of new tools to diagnose and treat cancer. Through the Cancer Care Network, UC Davis collaborates with a number of hospitals and clinical centers throughout the Central Valley and Northern California regions to offer the latest cancer care. Its community-based outreach and education programs address disparities in cancer outcomes across diverse populations. For more information, visithttp://cancer.ucdavis.edu ...
http://www.healthnewsdigest.com/news/Cancer_Issues_660/Pancreatic-Surgery-Complications-Impact-Hospital-Costs-More-Than-Length-of-Stay.shtml
Hospital Affiliations - Dept of Medicine, Jacobs SMBS - University at Buffalo  Hospital Affiliations - Dept of Medicine, Jacobs SMBS - University at Buffalo
A National Cancer Institute-designated comprehensive cancer center. For more than a century, RPCIs physician-scientists have made fundamental contributions to reduce the cancer burden and helped set national standards for cancer care, research and education. ...
http://medicine.buffalo.edu/departments/medicine/about/hospitals.html
Required Reading: Advancing Immuno-Oncology in the Community Setting | ACCCBuzz  Required Reading: "Advancing Immuno-Oncology in the Community Setting" | ACCCBuzz
Chair, Institute for Clinical Immuno-Oncology, Advisory Committee. Along with their copies copy of the January/February Oncology Issues, ACCC members will receive "Advancing Immuno-Oncology in the Community Setting," the inaugural white paper from the Institute for Clinical Immuno-Oncology (ICLIO), an institute of the Association of Community Cancer Centers (ACCC).. As members of the oncology community well know, the last five years have brought us thrilling advances in immunotherapy. Weve seen the introduction of checkpoint inhibitors and vaccines that are unleashing the power of an individuals immune system to fight cancer. In the past few months, weve witnessed a surge of new FDA indications for immunotherapy agents in a number of disease sites, including melanoma, lung cancer, and renal cell carcinoma.. Immuno-oncology is now emerging as the fourth pillar of cancer treatment. It is a new field, bringing new promise and new challenges for patients, providers, and payers.. As Chair of the ...
http://www.accc-cancer.org/ACCCbuzz/required-reading-advancing-immuno-oncology-in-the-community-setting/
OT: Invited to participate in vaccine research study - Bike Forums  OT: Invited to participate in vaccine research study - Bike Forums
I received an invitation from the City of Hope (one of 40 National Cancer Institute-designated Comprehensive Cancer Centers, this one located in
https://www.bikeforums.net/fifty-plus-50/502754-ot-invited-participate-vaccine-research-study.html
ACCC Clinical Investigators Cite Negative Impact of Managed Care and Cost Containment on Oncology Clinical Trials | Cancer...  ACCC Clinical Investigators Cite Negative Impact of Managed Care and Cost Containment on Oncology Clinical Trials | Cancer...
The Asscoiation of Community Cancer Centers (ACCC), at a meeting of the Collaborative Research Group (CRG), announced new study 1
http://www.cancernetwork.com/articles/accc-clinical-investigators-cite-negative-impact-managed-care-and-cost-containment-oncology-clinical
Plus it  Plus it
Background: Molecularly targeted drugs specific for mutated genes are increasingly the focus of novel clinical trials. However, molecular profiling of tumors is largely unavailable in community cancer centers, where nearly 80% of cancer patients (pts) are treated. In October 2012, Sarah Cannon Research Institute (SCRI) launched a community-based molecular profiling initiative to characterize the spectrum of molecular alterations in tumors. The profiling panel focused on potentially actionable mutations for the purpose of identifying candidates for treatment with specific targeted agents (FDA approved or investigational). Herein, we report the initial data from breast cancers (BC) profiled between October 2012 and May 2013.. Methods: Metastatic breast cancer (MBC) pts , 18 years of age with ECOG PS ≤ 2 who were candidates for treatment provided consent for tumor molecular profiling. Archival tumor specimens (tissue block or 10 unstained slides) obtained from either the primary or metastatic ...
http://cancerres.aacrjournals.org/content/73/24_Supplement/PD4-3
Nippon 日本 心得帖: Cancer centers release survival rates ( Japan)  Nippon 日本 心得帖: Cancer centers release survival rates ( Japan)
By MASAHIKO IDEGAWA, The Asahi Shimbun. The Japanese Association of Clinical Cancer Centers for the first time released the five-year survival rates of cancer patients along with the names of the medical institutions. The data released Thursday about patients suffering from stomach, breast, lung and colon cancers show a big difference in the survival rates at the 30 member institutions. For stomach cancer, for example, the National Cancer Center Hospital in Tokyos Tsukiji district had the highest five-year survival rate, at 84.1 percent. The lowest rate was 45.5 percent at an institution that was not named. The association released the names and the rates in response to growing demands from patients for treatment results at specific hospitals. The association also wants to encourage each cancer center to analyze the reasons for the discrepancies in the survival rates so that all the hospitals will be able to provide equal levels of treatment. However, the Ministry of Health, Labor and Welfare ...
http://hcjapan.blogspot.com/2007/10/cancer-centers-release-survival-rates.html
Cancers | Free Full-Text | Head and Neck Sarcomas: A Comprehensive Cancer Center Experience  Cancers | Free Full-Text | Head and Neck Sarcomas: A Comprehensive Cancer Center Experience
Head/neck sarcomas are rare, accounting for about 1% of head/neck malignancies and 5% of sarcomas. Outcomes have historically been worse in this group, due to anatomic constraints leading to difficulty in completely excising tumors, with high rates of local recurrence. We retrospectively analyzed cases of head/neck soft tissue sarcomas (STS) and osteogenic sarcomas managed in a multi-disciplinary setting at Fox Chase Cancer Center from 1999-2009 to describe clinicopathologic characteristics, treatment, outcomes, and prognostic factors for disease control and survival. Thirty patients with STS and seven patients with osteogenic sarcoma were identified. Most STS were high grade (23) and almost all were localized at presentation (28). Common histologies were synovial cell (6), rhabdomyosarcoma (5), angiosarcoma (4), liposarcoma (4) and leiomyosarcoma (3). The type of primary therapy and disease outcomes were analyzed. Cox proportional hazards regression analysis was performed to identify predictors of
http://mdpi.com/2072-6694/5/3/890
About the Gastrointestinal Cancer Program | Fox Chase Cancer Center - Philadelphia, PA  About the Gastrointestinal Cancer Program | Fox Chase Cancer Center - Philadelphia, PA
Fox Chase is home to some of the nations top gastrointestinal cancer specialists and support staff-a multidisciplinary team of professionals who work together to diagnose and treat gastrointestinal abnormalities and gastrointestinal cancer.
https://www.foxchase.org/clinical-care/departments-programs/clinical-programs/gastrointestinal-cancer/about
Chemistry and Cancer Scientific Program: Harold C. Simmons Comprehensive Cancer Center - UT Southwestern, Dallas, TX  Chemistry and Cancer Scientific Program: Harold C. Simmons Comprehensive Cancer Center - UT Southwestern, Dallas, TX
The Chemistry and Cancer Program combines the expertise of synthetic and medicinal chemists, molecular biologists, biochemists, structural biologists, and clinician-scientists to discover, design, and optimize drug-like small molecules that regulate biolo
http://www.utsouthwestern.edu/simmons/research/scientific-programs/chemistry-cancer/
Marymac5522s Story  Marymac5522's Story
I have been diagnosed as triple negative invasive found in the ducts. It has been a comedy of errors but a lesson in getting good diagnosis of your biopsy results. "Let me first start with the fact that there is significant familial breast cancer (Im the 9th occurence in 6 people on my dads side)...and no one is BRCA positive (including me). "Heres the story: "Feb: Something seen on mammogram, resulting in another mammo and then ultrasound, recommending needle biopsy. "Mar: Local breast surgeon at regional cancer center says, Its tiny, probably nothing. "Apr: Needle biopsy done by regional cancer center breast surgeon, lab read as hyperplasia in the duct (pre-cancer pre-DCIS) "June: (Because there is no urgency, late June appointment) for excisional biopsy aka lumpectomy. Because hyperplasia was expected, there was no node testing. Same local lab read the results as Stage 0 DCIS, high grade, ER+ 7%, PR-; suggested I should see oncologist and radiologist here at regional cancer center and ...
http://www.breastcancer.org/community/acknowledging/triple-negative/marymac5522
Cancer Treatment & Cancer Research | City of Hope Comprehensive Cancer Center | Los Angeles, CA  Cancer Treatment & Cancer Research | City of Hope Comprehensive Cancer Center | Los Angeles, CA
City of Hope cancer treatment and research center in southern California is rated a top cancer hospital by USNews. If youve been diagnosed with cancer, call us at 800-826-4673.
https://www.cityofhope.org/homepage?gclid=CjgKEAjw2dqcBRC2q-LXjpfxjnQSJAAeYF5LI0fuoSgxSU1AzWyi9qgGRImyn12a2a7SflZj4oMbMfD_BwE
复旦大学 Fudan University - Affiliated Hospitals  复旦大学 Fudan University - Affiliated Hospitals
Fudan University Shanghai Cancer Center was established in 1931， which is the first hospital specializing in cancer in China. FUSCC is now an AAA (a sign of top hospitals according to the evaluation system by Chinese Ministry of Health) comprehensive cancer center under the auspices of the Ministry of Health, P. R. China. As the only comprehensive cancer center in Shanghai, FUSCC has the overwhelming advantage of specialized multidisciplinary cancer treatment. It is also a non-profit organization and a university-affiliated hospital devoted to the healthcare of the cancer patients. A history of eighty years has made a trustworthy reputation for the center. FUSCC focus on the early diagnostic and early treatment of cancer with multidisciplinary treatment that strictly follows international standards. Surgery, radiotherapy, chemotherapy, traditional Chinese medicine (TCM), interventional therapy and biotherapy are combined to yield optimal outcomes.. The oncology program has become the key ...
http://www.fudan.edu.cn/en/channels/view/63/
Lung Cancer Program. Lung Cancer Program 1 - PDF  Lung Cancer Program. Lung Cancer Program 1 - PDF
The Lung Cancer Program at St. Joseph Hospital takes a comprehensive and individualized approach to patient care. We offer a wide range of services that include cancer prevention, CT lung cancer screening,
http://docplayer.net/1273961-Lung-cancer-program-lung-cancer-program-1.html
Early versus delayed use of tyrosine kinase inhibitors for thyroid cancer - European Medical Journal  Early versus delayed use of tyrosine kinase inhibitors for thyroid cancer - European Medical Journal
Recent advances in the biological understanding of thyroid cancer have led to the development of targeted therapies, such as the tyrosine kinase inhibitors (TKIs) sorafenib and lenvatinib, which have been approved by the US Food and Drug Administration for the treatment of differentiated thyroid cancer. At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Makoto Tahara, MD, PhD, from National Cancer Center Hospital East, Kashiwa, Japan, evaluates the efficacy and safety of early versus delayed use of TKIs for the management of patients with thyroid cancer.
http://emjreviews.com/videos/early-versus-delayed-use-of-tyrosine-kinase-inhibitors-for-thyroid-cancer/
Message from the Director | National Cancer Center Reseach Institute  Message from the Director | National Cancer Center Reseach Institute
My name is Hiroyuki Mano, and I was appointed as Director of National Cancer Center Research Institute on April 1, 2016. This Research Institute was established in 1962 as one of the main parts of the National Cancer Center, and has been driving cancer research in Japan ever since. The Center was designated a National Research and Development Agency in April 2015. Since then, there is more demand than ever to promote research and development and to maximize results. In assuming the role of Director of this Institute, I am humbled by this heavy social responsibility, but I am devoting all my efforts to the tasks at hand.. Presently, we are facing major changes in the treatment of cancer. As new medications for molecular targeted therapy and immunosuppression are continuously released, patient-by-patient, personalized treatment based on genomic information from tumors is sought. This means more than simply accelerating drug research; it means great changes to the system of diagnosis and medical ...
https://www.ncc.go.jp/en/ri/director/about/greeting/
Michigan Today » Cancer research: High risk = high reward  Michigan Today » Cancer research: High risk = high reward
The gift builds on the exceptional academic strength of the University - in which 103 graduate programs are ranked in the top 10 nationally - and the prestige of the Comprehensive Cancer Center, one of only 45 such programs in the country.. The Forbes Institute will foster collaboration across the University. This is already a hallmark of the Cancer Center: its members come from 48 University departments across nine schools, demonstrating a breadth of interdisciplinary collaboration not seen elsewhere.. "The biggest advances in cancer will come at the intersection of disciplines. Its not medicine alone, but medicine working with engineering, pharmacy and other schools to create true innovation," says Max S. Wicha, M.D., founding director emeritus of the University of Michigan Comprehensive Cancer Center.. U-M has launched 55 companies since 2011. More than 10 of these companies are led by faculty affiliated with the Cancer Center. With such experience, the new institute offers tremendous ...
http://michigantoday.umich.edu/cancer-research-high-risk-high-reward/
New drug combination for advanced breast cancer delays disease progression  New drug combination for advanced breast cancer delays disease progression
The study results also suggest that the drug combination can delay or overcome resistance to fulvestrant. The combination should be studied in other populations of patients, Adelson added, including those who are newly diagnosed with metastatic breast cancer and those who have already progressed on fulvestrant.. Adelson was the studys principal investigator for the New York Cancer Consortium. Study support included funding from National Cancer Institute/CTEP; and Millenium, the Takeda Oncology Company.. Yale Cancer Center (YCC) is one of only 41 National Cancer Institute (NCI)-designated comprehensive cancer centers in the nation and the only such center in Connecticut. Comprehensive cancer centers play a vital role in the advancement of the NCIs goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment.. ...
http://www.innovations-report.com/html/reports/life-sciences/new-drug-combination-for-advanced-breast-cancer-delays-disease-progression.html
UAB Comprehensive Cancer Center: July 2014  UAB Comprehensive Cancer Center: July 2014
Fantastic. I have been doing cancer research for 10 years. Ive been here five of those years. The first five was at a smaller hospital. It was a great stepping stone to coming here. I think it would have been harder had I not had the experience at a lower level and a lower volume. The volume here is massive. You know we are one of 40 NCI-designated cancer centers in the United States, I mean to be part of that is a big deal. The people that do research here are just passionate about what they do. I think that that is what it takes if you are going to do research. No matter if youre doing bench site or youre doing therapeutic, you have to be passionate because it is tedious." ...
http://uabccc.blogspot.com/2014/07/
UAB Comprehensive Cancer Center: 2014  UAB Comprehensive Cancer Center: 2014
Fantastic. I have been doing cancer research for 10 years. Ive been here five of those years. The first five was at a smaller hospital. It was a great stepping stone to coming here. I think it would have been harder had I not had the experience at a lower level and a lower volume. The volume here is massive. You know we are one of 40 NCI-designated cancer centers in the United States, I mean to be part of that is a big deal. The people that do research here are just passionate about what they do. I think that that is what it takes if you are going to do research. No matter if youre doing bench site or youre doing therapeutic, you have to be passionate because it is tedious." ...
http://uabccc.blogspot.com/2014/
Breast Health: Definitions, Alternative Names, Considerations, Causes, Imagery: UCLA Breast Center  Breast Health: Definitions, Alternative Names, Considerations, Causes, Imagery: UCLA Breast Center
Breast Health Information: Definitions, Alternative Names, Considerations, Causes, Imagery: UCLA Breast Center: UCLA Breast Center Santa Monica, Westwood Revlon/ UCLA Breast Center
http://breastcenter.ucla.edu/breast-health-center
Brain Cancer: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center  Brain Cancer: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Cancers that attack and invade the brain present some of the greatest challenges in cancer medicine and research. Our clinicians and scientists specialize in adult and pediatric brain cancers. They lead and engage in international collaborations and have expertise that spans many specialties, including medical oncology, neurology, brain surgery, radiation oncology, and pediatric oncology.. This team science approach, which also involves laboratory scientists, is aimed at deciphering the basic biology of brain cancer, uncovering biomarkers of brain cancer and developing new treatment strategies. Our experts are unraveling the complex molecular interactions that conspire to cause brain cancers by altering gene function and cell signaling.. In brain cancer, perhaps more so than any other type of cancer, researchers are focused on developing methods that destroy cancer cells without harming normal cells. Investigators and clinicians are taking advantage of exciting discoveries in cancer immunology ...
https://www.hopkinsmedicine.org/kimmel_cancer_center/research_clinical_trials/research/brain_cancer/index.html
HPV Vaccine Effectiveness in Question · Guardian Liberty Voice  HPV Vaccine Effectiveness in Question · Guardian Liberty Voice
According to the doctors, the concern is that human papillomavirus can lead to lethal cervical, esophagus and other cancers. Recently, 69 National Cancer Institute-chosen cancer centers sent a letter to the CDC sanctioning the recommendations. Among these select few organizations were the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.. Some of these approved recommendations endorse that children aged 11 to 12, under the new guidelines, should obtain two amounts of the HPV vaccine no less than six months apart. A three-dose series is recommended for those older than 15.. They stand by these recommendations due to the 79 million individuals in the United States that are disease-ridden with HPV. They are worried that these numbers seem to be increasing rather than decreasing. The CDC reports that over 39,000 different cancers connected to HPV are found each year in the United States.. Whereas, Dr. ...
http://guardianlv.com/2017/01/hpv-vaccine-effectiveness-question/
Breast Cancer Risk Factors - ECCC | Edwards Comprehensive Cancer Center - Huntington, WV  Breast Cancer Risk Factors - ECCC | Edwards Comprehensive Cancer Center - Huntington, WV
All women are at risk for breast cancer. Men can also get breast cancer, but it is rare. Except for skin cancer, breast cancer is the most common cancer in women of all combined major racial and ethnic groups in the United States. Breast cancer forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare. ...
http://edwardsccc.org/cancer-risk-and-prevention/breast-cancer-risk-factors/
UConn Advance - October 9, 2007 - Experts say understanding risk factors first step to cancer prevention  UConn Advance - October 9, 2007 - Experts say understanding risk factors first step to cancer prevention
The first step for women who want to reduce their risk of breast, ovarian, and other cancers is to thoroughly understand their risk factors, including family history. The second step is to adopt an ongoing, personalized prevention plan that reflects their unique risks.. That was the message from experts with the Health Centers Neag Comprehensive Cancer Center during a Discovery Series panel discussion on Sept. 25. "Throughout my career, Ive come to see each cancer - especially ovarian cancer, which is very difficult to treat when detected late - as a missed opportunity for prevention," said Dr. Molly Brewer, director of the Health Centers Division of Gynecologic Oncology. Brewer, a nationally recognized expert, said one of the reasons she joined the Health Center faculty last year was the opportunity to focus her practice on prevention. Under her leadership, the Health Center recently started a new Womens Cancer Prevention Program within the Neag Comprehensive Cancer Center.. Brewer and the ...
http://advance.uconn.edu/2007/071009/07100910.htm
Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center. -...  Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center. -...
This retrospective cohort trial evaluated the safety and efficacy of ertapenem for the treatment of bacterial infections in patients with cancer.
http://adisinsight.springer.com/trials/700264051?error=cookies_not_supported&code=ca56d27e-ea81-435c-879a-2f96b19e0e6a
Patients underlying health linked to worse outcomes for melanoma, U-M study finds - Healthcanal.com : Healthcanal.com  Patients' underlying health linked to worse outcomes for melanoma, U-M study finds - Healthcanal.com : Healthcanal.com
A new study from the University of Michigan Comprehensive Cancer Center finds that patients with decreased core muscle density were more likely to see their cancer spread to distant parts of the body. These findings may also support the idea that the patients biological response to a tumor is important in controlling the spread of melanoma. Patients whose systems are less able to mount a response may be more prone to their cancer spreading.. The researchers believe that identifying those patients who are at higher risk of poor outcomes could impact treatment decisions, including the success of new immunotherapy drugs. And potentially, if this degenerative muscle loss, called sarcopenia, can be reversed, patients might have better outcomes.. The study, which appears online in Annals of Surgical Oncology, looked at 101 patients treated for stage III melanoma at the U-M Comprehensive Cancer Center. Researchers examined CT scans for each patient to measure the area and density of a core muscle ...
https://www.healthcanal.com/cancers/20195-patients-underlying-health-linked-to-worse-outcomes-for-melanoma-u-m-study-finds.html
Location / Hours | Robert H. Lurie Comprehensive Cancer Center - Flow Cytometry Core Facility  Location / Hours | Robert H. Lurie Comprehensive Cancer Center - Flow Cytometry Core Facility
From I-90/94: Exit at East Ohio Street, merge into far left lane, and turn left at the first traffic light onto Orleans Avenue, going north. Merge into the far right lane and turn right at West Erie Street, going east. At Dearborn Street (a one way street) turn left and go two blocks north. Turn right at Superior Street, drive five blocks east, cross Fairbanks Court, and the Ward building backdoor is on the left side. Entry is through the Method Atrium at 310 East Superior Street.. Lake Shore Drive: Coming from the north on southbound Lake Shore Drive, stay in the far right lane and exit at Chestnut Street. Proceed two blocks west and turn left at Mies Van Der Rohe Way. Go two blocks south and turn left at Chicago Avenue. The Ward Building is on the right at 303 East Chicago Avenue.. Coming from the south on northbound Lake Shore Drive, stay in the far left lane and exit left at Chicago Avenue. Please consult campus map below for parking. Another good place to park is the parking lot of the ...
http://rhlccflow.facilities.northwestern.edu/contact/location/
Tempus and University of California Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership for Cancer...  Tempus and University of California Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership for Cancer...
CHICAGO, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data and University of California Davis Comprehensive C
https://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=239928
News Releases: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center  News Releases: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Researchers at the Johns Hopkins Brady Urological Institute, Wake Forest University and the Karolinska Institute in Sweden have identified an array of gene markers for hereditary prostate cancer that, along with family history for the disease, appear to raise risk to more than nine times that of men without such markers. The panel, gleaned from a study of more than 4,000 Swedes, found that these markers are common and could account for nearly half of the prostate cancer cases in this study. Results are published online in the Jan. 16 edition of the New England Journal of Medicine.. ...
https://www.hopkinsmedicine.org/kimmel_cancer_center/news_events/news_releases.html?filterYear=2008
Comprehensive Cancer Center at The Miriam Hospital - University Medicine  Comprehensive Cancer Center at The Miriam Hospital - University Medicine
University Medicine is a non-profit, academic, multi-specialty medical group with practices in Providence, RI and its surrounding communities.
http://www.umfmed.org/3/index.php/2013-05-13-03-21-37/2013-05-13-03-28-36/2014-03-10-16-33-28
Gut-throat competition: U-M research on digestive tract bacteria yields surprising findings - Healthcanal.com : Healthcanal...  'Gut'-throat competition: U-M research on digestive tract bacteria yields surprising findings - Healthcanal.com : Healthcanal...
Nuñez and first author Nobuhiko Kamada, Ph.D., a postdoctoral fellow, made the findings by studying mice that they infected with C. rodentium - the rodent equivalent of harmful E. coli. The study included specially bred germ-free mice that lacked all the "good" gut bacteria that normal mice and humans harbor.. Both Nuñez and Kamada are members of the U-M Medical Schools Department of Pathology and the U-M Comprehensive Cancer Center, and the work fits into their broader investigations of how inflammation and immunity play a role in the bodys response to cancer as well as infections.. Fittingly, Nuñez holds the Paul H. de Kruif Professorship in Pathology, named for the U-M graduate who wrote Microbe Hunters, a pivotal 1926 book on the history of infectious disease research. He is also a member of the U-M Comprehensive Cancer Center.. In the new paper, the team adds a new chapter to the understanding of how pathogenic bacteria gain a foothold in the gut - literally - by turning on virulence ...
https://www.healthcanal.com/digestive-system/29214-gut-throat-competition-u-m-research-on-digestive-tract-bacteria-yields-surprising-findings.html
Mochtar Riady Comprehensive Cancer Centre | First Reit  Mochtar Riady Comprehensive Cancer Centre | First Reit
Provides high dose brachytherapy, radio-immunotherapy (RIT), radiopeptide therapy, molecular imaging with PET/Computed Tomography (PET/ CT) and Single Photon Emission Computed Tomography/CT (SPECT/ CT) scanning, chemotherapy, complementary therapy, Linear Accelerator treatment, Multi Slice CT, high field strength MRI, angiography, in-house clinical trials and integrated IT and PACS/RIS ...
http://www.first-reit.com/portfolio-mrccc.html
Jonsson Comprehensive Cancer Center - Progressive Metastatic Castrate Resistant Prostate Cancer - CheckOrphan  Jonsson Comprehensive Cancer Center - Progressive Metastatic Castrate Resistant Prostate Cancer - CheckOrphan
The dosage of trametinib for oral administration is 2mg once daily. The patient is instructed to take the trametinib oncedaily dose at approximately the same time each day, by mouth with approximately 200 mL (almost 1 cup) of water on an empty stomach, either 1 hour before or 2 hours after a meal. ...
http://www.checkorphan.org/access-programs/jonsson-comprehensive-cancer-center-progressive-metastatic-castrate-resistant-prostate
Community Cancer Care Much Cheaper Than Hospital  Community Cancer Care 'Much Cheaper' Than Hospital
Cancer care is significantly more expensive when delivered in a hospital outpatient setting than in a community oncology practice. A new study shows that it cost almost 60% more, or $90,144 per year, for a patient to receive chemotherapy in the hospital, and patients who received treatment in the hospital setting were more likely to visit the emergency department after treatment.
https://www.rxlist.com/script/main/art.asp?articlekey=207530
Guide to Patient Support and Regional Cancer Services. Information for cancer patients, carers and families in the ACT and...  Guide to Patient Support and Regional Cancer Services. Information for cancer patients, carers and families in the ACT and...
Guide to Patient Support and Regional Cancer Services Information for cancer patients, carers and families in the ACT and surrounding region Accessibility The ACT Government is committed to making its
http://docplayer.net/996260-Guide-to-patient-support-and-regional-cancer-services-information-for-cancer-patients-carers-and-families-in-the-act-and-surrounding-region.html
Head and Neck Cancer Program | Cedars-Sinai  Head and Neck Cancer Program | Cedars-Sinai
The Head and Neck Cancer Program at the Samuel Oschin Comprehensive Cancer Institute specializes in accurate diagnosis and advanced care for patients with benign and malignant tumors of the head and neck.
https://www.cedars-sinai.org/programs/cancer/we-treat/head-and-neck.html
Childrens Cancer Hospital | MD Anderson Cancer Center  Children's Cancer Hospital | MD Anderson Cancer Center
MD Anderson Childrens Cancer Hospital brings hope to families and children diagnosed with cancer. Discover one of the nations leading pediatric cancer centers.
https://www.mdanderson.org/patients-family/diagnosis-treatment/care-centers-clinics/childrens-cancer-hospital.html
Pediatric Care - CARE CENTER HOSPITAL FOR ANIMALS  Pediatric Care - CARE CENTER HOSPITAL FOR ANIMALS
Welcome to Care Center Hospital for Animals. Your family Veterinarians in Coldwater, MI. Call us at 517-278-5631 to schedule your appointment today.
http://www.carecenterhospital.com/id-3208
Thyroid Cancer Program Hospital in Delhi, India | Doctors & Specialists - BLK Hospital  Thyroid Cancer Program Hospital in Delhi, India | Doctors & Specialists - BLK Hospital
BLK Hospital is best thyroid cancer program hospital in Delhi, India by the top Surgeons, Doctors & Specialist. Book an appointment online for thyroid cancer treatment & surgeries.
https://www.blkhospital.com/cancer-centre/subspeciality/thyroid-cancer-program
Lung Cancer Program  Lung Cancer Program
The Huntsville Hospital Lung Cancer Program is a multidisciplinary effort of experts dedicated to delivering the highest-quality care and service to patients with suspected or diagnosed lung cancer. By working collaboratively across disciplines, and in cooperation with the Southeast Lung Alliance, our team integrates and coordinates a complex process into a seamless service that helps deliver quality service and care for patients with suspected or diagnosed lung cancer.. Together, we offer the latest innovations in lung cancer detection and treatment, including molecular mapping that enables physicians to personalize care based on a patients genetic makeup. Our services and capabilities also include:. ...
https://www.huntsvillehospital.org/lung-cancer-program
DVIDS - News - Survey says SAMMC cancer program ranks among nations best  DVIDS - News - Survey says SAMMC cancer program ranks among nation's best
The No. 1 health risk for our older population is cancer," he said, "and as a full cancer program, we have to be able to address that need and do it well, while always looking at how we can improve our cancer care." ...
https://www.dvidshub.net/news/91890/survey-says-sammc-cancer-program-ranks-among-nations-best
The US Cancer Program and Specific Types of Cancer, 1975-2007: A Failure - Part 2 - Next Level Nutrition  The US Cancer Program and Specific Types of Cancer, 1975-2007: A Failure - Part 2 - Next Level Nutrition
Introduction In a recent article, we assessed the US cancer program by analyzing the overall incidence and mortality rates of all cancers combined, over 1975-2006.1 This study uses the same framework to
http://next-level-nutrition.com/?p=6627
Colon and Rectal Cancer Program | BIDMC of Boston  Colon and Rectal Cancer Program | BIDMC of Boston
BIDMCs Colon & Rectal Cancer Program offers multidisciplinary expertise in diagnosing and treating cancers of the large intestine, small intestine and anus.
https://www.bidmc.org/centers-and-departments/cancer-center/cancer-center-programs-and-services/colon-and-rectal-cancer-program
Cancer Hospitals, Cancer Test Centers and Cancer Institutes : Cancer Resources  Cancer Hospitals, Cancer Test Centers and Cancer Institutes : Cancer Resources
... - In this section you can find out Cancer Hospitals, Test Centers and Institutes that provides the Cancer treatment facilities to the customers. Know about top Cancer Hosp
http://www.onlymyhealth.com/cancer-resources-1317981473.html
Cancer lines :: State Publications  Cancer lines :: State Publications
LU N C L i n ecb e r g e ria C o mnpnr e h e n seicv e C aesn c e r Cre n t e r The Cancer Programs of UNC-Chapel Hill & UNC Health Care Fall 2003 Not all scientific research occurs in classic laboratory set-tings. Some of the best science is done in communities and clinics, using participants drawn from the public, high-risk populations and patients to develop hypotheses, test concepts and create treatment plans. "Population-based studies are the laboratory for research aimed at improving the control of cancer," said Barbara Rimer, UNC alumni distinguished professor of health behavior and health education in the School of Public Health and deputy director for population sciences at the UNC Lineberger Comprehensive Cancer Center. "We have to understand peoples health practices, health experiences-how their genetic make-up, knowledge, attitudes, health practices and healthcare experiences affect their chances of getting, surviving and living beyond cancer," she said. "We must study people in ...
http://digital.ncdcr.gov/cdm/compoundobject/collection/p249901coll22/id/192986/show/205762/rec/11
Cancer lines :: State Publications  Cancer lines :: State Publications
LU N C L i n ecb e r g e ria C o mnpnr e h e n seicv e C aesn c e r Cre n t e r The Cancer Programs of UNC-Chapel Hill & UNC Health Care Fall 2003 Not all scientific research occurs in classic laboratory set-tings. Some of the best science is done in communities and clinics, using participants drawn from the public, high-risk populations and patients to develop hypotheses, test concepts and create treatment plans. "Population-based studies are the laboratory for research aimed at improving the control of cancer," said Barbara Rimer, UNC alumni distinguished professor of health behavior and health education in the School of Public Health and deputy director for population sciences at the UNC Lineberger Comprehensive Cancer Center. "We have to understand peoples health practices, health experiences-how their genetic make-up, knowledge, attitudes, health practices and healthcare experiences affect their chances of getting, surviving and living beyond cancer," she said. "We must study people in ...
http://digital.ncdcr.gov/cdm/compoundobject/collection/p249901coll22/id/192986/show/205762/rec/15
BSN: Resource Details: Clodagh OShea  BSN: Resource Details: Clodagh O'Shea
Founded in 1978, the Moores UCSD Cancer Center is one of just 41 centers in the United States to hold a National Cancer Institute (NCI) designation as a Comprehensive Cancer Center. As such, it ranks among the top centers in the nation conducting basic and clinical cancer research, providing advanced patient care and serving the community through outreach and education programs. • In 1998, an endowment of $1 million established the Chugai Chair for Cancer Research for the Center Director.. • The Cancer Center is one of five Organized Research Units (ORU) of the UCSD School of Medicine. As an ORU, we stimulate cancer research on the La Jolla campus, stimulate scientific collaboration, and nurture junior cancer investigators. • One of two USA branches of the Ludwig Institute for Cancer Research is located on the UCSD campus, which enables powerful scientific synergies with members of the Cancer Center.. • The Cancer Center is working in close collaboration with UCSDs Scripps Institution ...
http://www.biotechsciencenews.com/Resource/1307-Clodagh-O%E2%80%99Shea%09%09.html
Action Cancer Hospital  Action Cancer Hospital
... in Delhi: Get complete information about Action Cancer Hospital in Delhi and its doctors list by speciality with complete address, appointment phone numbers, reviews, services and Website Detail | Sehat.
https://www.sehat.com/action-cancer-hospital-delhi
Top Trachea Cancer Hospitals in Kolkata | Credihealth  Top Trachea Cancer Hospitals in Kolkata | Credihealth
View details of top trachea cancer hospitals in Kolkata. Get guidance from medical experts to select best trachea cancer hospital in Kolkata
https://www.credihealth.com/hospitals/kolkata/trachea-cancer
Cancer Services | Hillcrest Hospital  Cancer Services | Hillcrest Hospital
Learn about the cancer services and treatment options at Hillcrest Hospital. To learn more about Radiation Oncology, download the Patient and Family Guide.
https://my.clevelandclinic.org/locations/hillcrest-hospital/specialties/cancer
Archived News  Archived News
HOLLYWOOD, Fla., March 19, 2007 - Failure to recognize the role of stem cells in metastasis may have led cancer researchers up "blind alleys" in countless clinical trials, said Max S. Wicha, M.D., founding director and distinguished professor of internal medicine at the University of Michigan Comprehensive Cancer Center, speaking at the National Comprehensive Cancer Networks 12th Annual Conference.. With tumor shrinkage the primary guidepost of any new treatment, valuable therapies may be aborted too early in their experimental life, he said. At the same time, clinical-trial measurements that focus only on a tumors diminishing size may explain why some new therapeutic treatments have failed to work. If the tumors stem cells run amok even as the tumors girth diminishes, a patients life may be at stake.. The answer? Begin monitoring whether chemotherapy and radiation treatments work to arrest cancers stem cells and their progenitors - i.e., those cells that can make exact copies of ...
https://www.nccn.org/about/news/newsinfo.aspx?NewsID=103
Blood and Bone Cancer Services for Children | Helen DeVos Childrens Hospital Services  Blood and Bone Cancer Services for Children | Helen DeVos Children's Hospital Services
Blood and bone cancer services program for children is a transplantation program at Helen DeVos Childrens Hospital that is the regions only pediatric blood and bone marrow transplantation program. Learn more
https://www.spectrumhealth.org/patient-care/services-and-treatment-detail-pages/blood-and-blood-cancer-services-for-children
Doctors and departments - Mayo Clinic  Doctors and departments - Mayo Clinic
Cancer research is conducted in coordination with the Mayo Clinic Cancer Center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center - recognition for an institutions scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.. ...
https://www.mayoclinic.org/diseases-conditions/esophageal-cancer/doctors-departments/ddc-20356093?mc_id=comlinkpilot&placement=bottom&p=1
October 3, 2016 - Case Comprehensive Cancer Center - Case Western Reserve University  October 3, 2016 - Case Comprehensive Cancer Center - Case Western Reserve University
Andrew SloanA new paper in the October issue of the journal Neurosurgical Focus finds the use of laser beneficial for the removal of large, "inoperable" glioblastoma (GBM) and other types of brain tumors. The paper is authored by Andrew Sloan, MD, and colleagues from University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine and Case Comprehensive Cancer Center (Wright J, et al. Neurosurg Focus. 2016 Oct; view video abstract).. Dr. Sloan and other investigators at the Case Comprehensive Cancer Center led the first in human trials, published in 2013, of a procedure with laser interstitial thermotherapy (LITT), a minimally invasive approach using a laser to "cook" a tumor through a tiny hole in the scalp and bone and the intra-operative MRI (iMRI) to fine tune the treatment rather than the surgeons direct vision.. However, one problem that he and other surgeons faced was tumor swelling. While LITT was successful for brain tumors smaller than the size of a ...
http://cancer.case.edu/about/news-pubs/news/releases/2016/2016oct03/
Nutrition Management Office | National Cancer Center Hospital  Nutrition Management Office | National Cancer Center Hospital
We created the assessment sheet corresponding to the prandial activities that we are performing through collaboration, and announced this to the Japan Society of Metabolism and Clinical Nutrition.. In addition, we are conducting research on nutrition and the diet management environment of cancer patients thanks to a cancer survivorship research grant from the Foundation for Promotion of Cancer Research.. I conducted the factual survey of the taste disorder in a stomach-cancer postoperative auxiliary treatment as a cancer research and development.. We participated in a seminar and symposium on cancer survivorship, holding such things as open classes, and performed the educational activities in the region.. The study meetings in 2015 were as follows:. ...
https://www.ncc.go.jp/en/ncch/specialist_ctr_depts/Nutrition_Management_Office/index.html
A Celebration of Life Through Bollywood Dance and Music | Rutgers Cancer Institute of New Jersey  A Celebration of Life Through Bollywood Dance and Music | Rutgers Cancer Institute of New Jersey
About The Cancer Institute of New Jersey. The Cancer Institute of New Jersey (www.cinj.org) is the states first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. CINJs physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. To make a tax-deductible gift to support CINJ, call 732-235-8614 or visit www.cinjfoundation.org. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School. The CINJ Network is comprised of hospitals throughout the state and provides a mechanism to rapidly disseminate important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Memorial Hospital, Carol G. Simon ...
http://cinj.org/PressReleases/SKNevent
Thymoma and Thymic Carcinoma Team - Vanderbilt-Ingram Cancer Center  Thymoma and Thymic Carcinoma Team - Vanderbilt-Ingram Cancer Center
A directory of doctors, health care providers and researchers who treat Thymoma and Thymic Carcinoma at the Vanderbilt-Ingram Cancer Center, Nashville, Tennessee - a National Cancer Institute-designated cancer center in the southeast, with affiliate hospitals in Tennessee, Kentucky and Alabama.
http://www.vicc.org/dd/dz/results.php?name=thymoma-and-thymic-carcinoma
NIH Guide: MINORITY-BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM  NIH Guide: MINORITY-BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
Full Text CA-96-016 MINORITY-BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM NIH GUIDE, Volume 25, Number 20, June 21, 1996 RFA: CA-96-016 P.T. 34, FF Keywords: Autoimmunity Oncology Disease Prevention+ Treatment, Medical+ Clinical Trial National Cancer Institute Letter of Intent Receipt Date: August 7, 1996 Application Receipt Date: September 25, 1996 PURPOSE The Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), is continuing the established cancer control effort, which involves practicing oncologists who serve large minority populations in the NCI clinical trials program. The Community Oncology and Rehabilitation Branch (CORB), DCPC, invites applications from domestic institutions with greater than 50 percent of new cancer patients from minority populations for cooperative agreements in response to this Minority-Based Community Clinical Oncology Program (Minority-Based CCOP) Request for Applications (RFA). Applicants for new and currently funded Minority-Based CCOPs ...
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-96-016.html
Gateway Regional Medical Center Hospital | Medical Malpractice Lawsuit :: Illinois Malpractice Attorneys  Gateway Regional Medical Center Hospital | Medical Malpractice Lawsuit :: Illinois Malpractice Attorneys
Medical malpractice lawyers for individuals and facility for cases involving Gateway Regional Medical Center Hospital. Free case reviews. 888-424-5757
https://www.rosenfeldinjurylawyers.com/gateway-regional-medical-center-hospital.html
ASTRO And AUA Joint Guideline For Radiation Therapy After Prostatectomy Highlighted At ASTRO Annual Meeting - Redorbit  ASTRO And AUA Joint Guideline For Radiation Therapy After Prostatectomy Highlighted At ASTRO Annual Meeting - Redorbit
Guideline provides detailed direction on treatment options for prostate cancer patients. The American Society for Radiation Oncology (ASTRO) will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTROs 55th Annual Meeting, September 22-25, 2013, in Atlanta.. The guideline focuses on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence, and is a joint effort between ASTRO and the American Urological Association (AUA). The 81-page document represents an intensive collaboration among experts in the radiation oncology and urology fields, led by Richard K. Valicenti, MD, MBA, professor and chair of the department of radiation oncology at the University of California Davis Comprehensive Cancer Center in Sacramento, on behalf of ASTRO, and Ian M. Thompson Jr., MD, director of the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio and ...
http://www.redorbit.com/news/health/1112955032/astro-and-aua-joint-guideline-for-radiation-therapy-after-prostatectomy-highlighted-at-astro-annual-meeting/
Comparative efficacy, tolerability, and survival outcomes of various r | DDDT  Comparative efficacy, tolerability, and survival outcomes of various r | DDDT
Comparative efficacy, tolerability, and survival outcomes of various radiopharmaceuticals in castration-resistant prostate cancer with bone metastasis: a meta-analysis of randomized controlled trials Mutahir Tunio,1 Mushabbab Al Asiri,1 Abdulrehman Al Hadab,1 Yasser Bayoumi2 1Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia; 2Radiation Oncology, National Cancer Institute, Cairo University, Cairo, Egypt Background: A meta-analysis was conducted to assess the impact of radiopharmaceuticals (RPs) in castration-resistant prostate cancer (CRPC) on pain control, symptomatic skeletal events (SSEs), toxicity profile, quality of life (QoL), and overall survival (OS).Materials and methods: The PubMed/MEDLINE, CANCERLIT, EMBASE, Cochrane Library database, and other search engines were searched to identify randomized controlled trials (RCTs) comparing RPs with control (placebo or radiation therapy) in metastatic CRPC. Data were extracted and assessed for the risk of
https://www.dovepress.com/comparative-efficacy-tolerability-and-survival-outcomes-of-various-rad-peer-reviewed-article-DDDT-recommendation1
Los Angeles Radiation Oncology Center | The US Oncology Network  Los Angeles Radiation Oncology Center | The US Oncology Network
Robert Zimmerman, MD. Robert Zimmerman, MD is a Cum Laude graduate of the University of California, Los Angeles, where he earned his Bachelor of Science degree in Biology. He graduated from the UCLA School of Medicine as a member in the honorary medical society, Alpha Omega Alpha. He served his medical internship at UCLAs San Fernando Valley Program at the Olive View Medical Center and the VA Sepulveda Medical Center in California. Dr. Zimmerman completed his Radiation Oncology residency at the UCLA Department of Radiation Oncology in Los Angeles.. Dr. Zimmerman has done extensive research in cancer treatment and was the recipient of an American Cancer Society Clinical Oncology Fellowship and a Radiological Society of North America Roentgen Resident/Fellow Research Award. His scientific research work has resulted in numerous publications and presentations pertaining to Radiation Oncology. Dr. Zimmerman has served as Assistant Professor of Radiation Oncology at the Texas A&M University College ...
https://www.usoncology.com/patients/practices/greater-los-angeles-radiation-therapy-centers/los-angeles-radiation-oncology
AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Health FacilitiesSkilled Nursing FacilitiesEarly Detection of CancerResidential FacilitiesProstatic NeoplasmsOvarian NeoplasmsBreast NeoplasmsLung NeoplasmsStomach NeoplasmsColonic NeoplasmsAmbulatory Care FacilitiesFacility Design and ConstructionNeoplasm MetastasisNeoplasm InvasivenessUnited StatesNeoplasmsPancreatic NeoplasmsAssisted Living FacilitiesGene Expression Regulation, NeoplasticMice, NudeCancer VaccinesHealth Facility AdministrationRetrospective StudiesHealth Facilities, ProprietaryNeoplasm ProteinsUterine Cervical NeoplasmsSurvival AnalysisSurvival RatePublic FacilitiesHealth Facility PlanningPrognosisGenetic Predisposition to DiseaseProspective StudiesFollow-Up StudiesRiskAntineoplastic AgentsFacility Regulation and ControlRegistriesAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmCarcinoma, Squamous CellCarcinomaDisease ProgressionReverse Transcriptase Polymerase Chain ReactionRisk AssessmentUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungNational Cancer Institute (U.S.)QuestionnairesColorectal NeoplasmsCell Line, TumorGene Expression ProfilingReceptors, EstrogenXenograft Model Antitumor AssaysAge FactorsLong-Term CareTumor Markers, BiologicalNeoplasm StagingMutationSurvivorsOdds RatioRNA, MessengerRisk FactorsReceptor, erbB-2Rectal NeoplasmsNursing HomesNeoplasm Recurrence, LocalCombined Modality TherapyBlotting, WesternMultivariate AnalysisSensitivity and SpecificityNeoplasm TransplantationDisease-Free SurvivalProstate-Specific AntigenDNA, NeoplasmMammographyCell Transformation, NeoplasticEndometrial NeoplasmsSmokingRNA, Small InterferingLogistic ModelsDNA MethylationHealth Services AccessibilityAqueous HumorChemotherapy, AdjuvantMedical OncologyCell SurvivalToilet FacilitiesTumor Suppressor Protein p53Esophageal NeoplasmsFluorouracilMilitary FacilitiesGenotypeTamoxifenTransplantation, HeterologousNeoplastic Stem CellsJapanKaplan-Meier EstimateCisplatinReceptors, ProgesteroneAntineoplastic Agents, PhytogenicOligonucleotide Array Sequence AnalysisReproducibility of ResultsCell MovementGenes, BRCA1Antineoplastic Agents, HormonalDown-RegulationAntigens, NeoplasmSEER ProgramBreastDose-Response Relationship, DrugLiver NeoplasmsIncidenceClinical Trials as TopicAdenocarcinomaTumor BurdenDrug Screening Assays, AntitumorHead and Neck NeoplasmsCancer Care FacilitiesCell DivisionAnticarcinogenic AgentsPredictive Value of TestsNeoplasms, Radiation-InducedMouth NeoplasmsConfidence IntervalsNeoplasms, Hormone-DependentTreatment OutcomePolymorphism, GeneticCell CycleHomes for the AgedMolecular Targeted TherapyCarcinoma, Small CellCross-Sectional StudiesPaclitaxelOccupational ExposurePolymerase Chain ReactionCell ProliferationCell Growth ProcessesApoptosisPromoter Regions, GeneticQuality of LifeAmerican Cancer SocietyBone NeoplasmsReceptor, Epidermal Growth FactorRadiotherapyNeoplasms, Second PrimaryMicroRNAsTransfectionChinaProstateNeoplasms, Glandular and EpithelialRNA InterferenceAntibodies, MonoclonalNeovascularization, PathologicTumor Suppressor ProteinsUp-RegulationModels, BiologicalGene SilencingIntermediate Care FacilitiesSkin NeoplasmsGenes, Tumor SuppressorTumor Cells, CulturedTime FactorsGenital Neoplasms, FemaleDeoxycytidineTrabecular MeshworkGerm-Line MutationPrecancerous ConditionsGenes, NeoplasmNeoplasm GradingMice, SCIDDietTissue Array AnalysisGastrointestinal NeoplasmsAge DistributionPalliative CareAntimetabolites, AntineoplasticQuality of Health CareBase SequenceGenes, p53Receptors, AndrogenAnimals, LaboratoryPostmenopausePrevalenceSocioeconomic FactorsMaternal Health ServicesHealth Facility EnvironmentMolecular Sequence DataTaxoidsHCT116 CellsDrug Administration ScheduleMCF-7 CellsThyroid NeoplasmsRNA, NeoplasmDNA-Binding ProteinsEuropean Continental Ancestry GroupFlow CytometryOccupational DiseasesGene ExpressionImmunoenzyme TechniquesGene Knockdown Techniques

The relationship between physical activity facility proximity and leisure-time physical activity in persons with spinal cord...The relationship between physical activity facility proximity and leisure-time physical activity in persons with spinal cord...

ACA Accessibility Adolescents Adults Affordable Care Act Aging Assistive Technology Autism Bladder Dysfunction CDC Children ... National Breast Cancer Coalition for Women with Disabilities. *National Disability Navigator Resource Collaborative ... Perceived facility proximity was determined by a self-report "YES" versus "NO" presence measure, while actual facility ... Contrary to hypothesis, people living within a 30-minute wheel from an accessible facility were less likely to engage in heavy ...
more infohttps://www.aahd.us/abstract/the-relationship-between-physical-activity-facility-proximity-and-leisure-time-physical-activity-in-persons-with-spinal-cord-injury/

22 Cancer Care Facilities Receive CoC Outstanding Achievement Award22 Cancer Care Facilities Receive CoC Outstanding Achievement Award

The Commission on Cancer (CoC) has granted its year-end 2016 Outstanding Achievement Award to a select group of accredited U.S ... 22 Cancer Care Facilities Receive Outstanding Achievement Award from the Commission on Cancer of the American College of ... American College of Surgeons Media Press Releases 2017 Press Releases 22 Cancer Care Facilities Receive CoC Outstanding ... 16 Cancer Care Facilities Receive CoC Outstanding Achievement Award * Surveillance Safe for Non-cancerous Breast Lesion ...
more infohttps://www.facs.org/media/press-releases/2017/oaa022317

Browsing Publications by Subject Cancer Care FacilitiesBrowsing Publications by Subject "Cancer Care Facilities"

... 0-9. A. B. C. D. E. F. G. H. I. J. K. L. M. N. O. P. Q. R. S. T. U. ...
more infohttps://extranet.who.int/iris/restricted/handle/10665/26724/browse?authority=Cancer+Care+Facilities&type=mesh

New Facility Offers Leading-Edge Cancer Care | McKessonNew Facility Offers Leading-Edge Cancer Care | McKesson

... is now open and offering the latest cancer treatment services available to patients in Phoenix and the East Valley. ... Arizona Oncologys new state-of-the-art cancer treatment center, located at the Arizona State University Research Park (ASURP ... New facility developed by Ryan Companies US, Inc. offers leading-edge cancer care to growing East Valley region. Tempe, Ariz. ( ... This nearly 22,000 square-foot building is a hub for cancer care and the only one of its kind in the East Valley. The center ...
more infohttp://www.mckesson.com/about-mckesson/newsroom/press-releases/2017/arizona-oncology-opens-state-of-the-art-cancer-treatment-center/?utm_medium=feed&utm_source=rss&utm_campaign=news+syndication

16 Cancer Care Facilities Receive Outstanding Achievement Award from American College of Surgeons Commission on Cancer16 Cancer Care Facilities Receive Outstanding Achievement Award from American College of Surgeons Commission on Cancer

The Commission on Cancer (CoC) has granted its mid-year 2017 Outstanding Achievement Award to a select group of 16 accredited U ... 16 Cancer Care Facilities Receive Outstanding Achievement Award from American College of Surgeons Commission on Cancer. ... 16 Cancer Care Facilities Receive Outstanding Achievement Award from American College of Surgeons Commission on Cancer ... 16 Cancer Care Facilities Receive CoC Outstanding Achievement Award * Surveillance Safe for Non-cancerous Breast Lesion ...
more infohttps://www.facs.org/media/press-releases/2017/oaa110217

Cancer - palliative treatment ; Neoplasms ; Analgesia ; Palliative care ; Pain ; Cancer - patients ; Cancer - treatment ;...Cancer - palliative treatment ; Neoplasms ; Analgesia ; Palliative care ; Pain ; Cancer - patients ; Cancer - treatment ;...

Cancer - patients ; Cancer - treatment ; Cancer care facilities ; Tumours - therapy ; Neoplasms - drug therapy ; Cancer pain - ... Books on LibraryThing tagged Cancer - palliative treatment ; Neoplasms ; Analgesia ; Palliative care ; Pain ; ... Cancer - patients ; Cancer - treatment ; Cancer care facilities ; Tumours - therapy ; Neoplasms - drug therapy ; Cancer pain - ... Cancer - patients ; Cancer - treatment ; Cancer care facilities ; Tumours - therapy ; Neoplasms - drug therapy ; Cancer pain - ...
more infohttps://www.librarything.com/tag/Cancer+-+palliative+treatment+%3B+Neoplasms+%3B+Analgesia+%3B+Palliative+care+%3B+Pain+%3B+Cancer+-+patients+%3B+Cancer+-+treatment+%3B+Cancer+care+facilities+%3B+Tumours+-+therapy+%3B+Neoplasms+-+drug+therapy+%3B+Cancer+pain+-+treatment+%3B+Pain+-+drug+therapy

Floor Tiles in ProHealth Care Cancer Treatment Facility in WisconsinFloor Tiles in ProHealth Care Cancer Treatment Facility in Wisconsin

Terra Maestricht tiles were chosen for this healthcare facilitys interior floors and walls, mainly because of their warm ... Floor Tiles in ProHealth Care Cancer Treatment Facility in Wisconsin Floor Tiles in ProHealth Care Cancer Treatment Facility in ... The project, the ProHealth Care UW Cancer Center, was in charge of CannonDesign architects and completed in 2014. Heather ... Mosa Terra Maestricht collection was used for the interior design of a healthcare facility in Wisconsin. ...
more infohttps://www.archdaily.com/catalog/us/products/10489/floor-tiles-in-prohealth-care-cancer-treatment-facility-in-wisconsin-mosa

Cancer Care Facilities | The Chopra LibraryCancer Care Facilities | The Chopra Library

Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer ... Clinical research on acupuncture in cancer care is a new and challenging field in oncology. The results of clinical research ... SETTING: Urban cancer research center. SAMPLE: Terminally ill patients with cancer who had expressed a desire for hastened ... Journal of Cancer Education: The Official Journal of the American Association for Cancer Education ...
more infohttp://isharonline.org/tags/cancer-care-facilities

WHO HQ Library catalog › Results of search for su:{Cancer care facilities.}WHO HQ Library catalog › Results of search for 'su:{Cancer care facilities.}'

Quality of life in cancer patients, a current topic in cancer treatment and care : proceedings of the Workshop on Quality of ... The multidisciplinary care of cancer patients / European Health Committee.. by Council of Europe. Health Committee ... by International Union against Cancer Material type: Book; Format: print Publisher: Geneva : International Union against Cancer ... "Quality of Life in Cancer Patients". by Workshop on Quality of Life in Cancer Patients Tokyo) (1984: ...
more infohttps://kohahq.searo.who.int/cgi-bin/koha/opac-search.pl?q=su:%7BCancer%20care%20facilities.%7D

Cancer facilities left out of health care exchanges | The Spokesman-ReviewCancer facilities left out of health care exchanges | The Spokesman-Review

Some of Americas best cancer hospitals are off-limits to many of the people now signing up for coverage under the nations new ... health care program. Doctors and administrators say theyre concerned. So are some state insurance regulators. ... executive vice president of Seattle Cancer Care Alliance. Before President Barack Obamas health care law, a cancer diagnosis ... Cancer facilities left out of health care exchanges. Wed., March 19, 2014 ...
more infohttp://www.spokesman.com/stories/2014/mar/19/cancer-facilities-left-out-of-health-care/

Cardiopulmonary resuscitation in cancer patients: experience of an intensive care unit in a cancer centerCardiopulmonary resuscitation in cancer patients: experience of an intensive care unit in a cancer center

... in medical cancer patients. A retrospective analysis of the records of patients admitted between November 1985 and January 1992 ... Cancer Care Facilities. Female. Follow-Up Studies. Heart Arrest / etiology, mortality, therapy*. Humans. Intensive Care Units. ... Cardiopulmonary resuscitation in cancer patients: experience of an intensive care unit in a cancer center. ... Title: Bulletin du cancer Volume: 83 ISSN: 0007-4551 ISO Abbreviation: Bull Cancer Publication Date: 1996 Aug ...
more infohttp://www.biomedsearch.com/nih/Cardiopulmonary-resuscitation-in-cancer-patients/8869048.html

Overeating may worsen chronic illnesses, says HMC consultantOvereating may worsen chronic illnesses, says HMC consultant

Heart Hospital, Cancer Care Center get high-tech facilities. Special Eid celebrations to kick off Qatar Summer Festival. ... The Ministry of Public Health, HMC, and Primary Health Care Corporation have partnered again this year to re-launch the Ramadan ... He explained that most patients who experience the effects of overeating do not require emergency care. "When considering if ... up having to wait while we treat others with more serious conditions so we recommend these patients to visit their primary care ...
more infohttps://www.gulf-times.com/story/595824/Overeating-may-worsen-chronic-illnesses-says-HMC-consultant

Nerve Root InjectionsNerve Root Injections

Emory University breaks ground on facility to transform cancer care. November 12, 2019 ... Emory Healthcare becomes official health care provider of College Park Skyhawks. November 06, 2019 ...
more infohttp://www.emoryhealthcare.org/orthopedics/nerve-root-injections.html

Shoulder Treatments - Emory HealthcareShoulder Treatments - Emory Healthcare

Emory University breaks ground on facility to transform cancer care. November 12, 2019 ... Winship Cancer Institute teams up with the Atlanta Falcons. October 08, 2019 ... Emory Healthcare becomes official health care provider of College Park Skyhawks. November 06, 2019 ...
more infohttps://www.emoryhealthcare.org/orthopedics/shoulder-treatments.html

Medical and health interior design | DezeenMedical and health interior design | Dezeen

... cancer care centres, medical research buildings, dentists and doctors surgeries and more ... Leth & Gori converts Copenhagen chapel into cancer-care facility with colourful painted joinery. Leth & Gori has transformed a ... 19th-century chapel in Copenhagen into an activity centre for cancer patients, using a material palette influenced by the ... Architects explains how the firm used natural materials to create a calming environment inside a dentist training facility in ...
more infohttps://www.dezeen.com/interiors/health-interiors/

Health information and publications in Africa African Index Medicus DatabaseHealth information and publications in Africa African Index Medicus Database

3 result(s) search for keyword(s) Cancer Care Facilities Add the result to your basket Refine your search Generate the RSS ... Neoplasms - immunology Neoplasms - chemistry Cancer Care Facilities Kenya. Abstract: Background: Cancer is becoming a major ... Neoplasms - immunology Neoplasms - chemistry Cancer Care Facilities Kenya. Abstract: Background: Cancer is becoming a major ... Head and Neck Neoplasms - diagnosis Head and Neck Neoplasms - therapy Lymphoma Cancer Care Facilities Pediatrics Hospitals, ...
more infohttp://indexmedicus.afro.who.int/aim/opac_css/index.php?lvl=more_results&mode=keyword&user_query=Cancer+Care+Facilities&tags=ok

Browsing SEARO Publications by SubjectBrowsing SEARO Publications by Subject

Cancer Care Facilities [‎1]‎. Cardiovascular Diseases [‎3]‎. * * Browsing SEARO Publications by Subject * IRIS Home ...
more infohttps://apps.who.int/iris/handle/10665/136791/browse?type=mesh

Browsing Publications by SubjectBrowsing Publications by Subject

Cancer Care Facilities [‎2]‎. Cannabis [‎5]‎. Capacity Building [‎21]‎. Cape Verde [‎1]‎. ...
more infohttps://apps.who.int/iris/handle/10665/26724/browse?rpp=20&sort_by=-1&type=mesh&etal=-1&starts_with=C&order=ASC

Program Members | Yale Cancer CenterProgram Members | Yale Cancer Center

Cancer Care Facilities. *Chondrosarcoma. *Fibrous Dysplasia of Bone. *Fracture Fixation, Intramedullary. *Fractures, Ununited ... William H. Carmalt Professor of Surgery; Chair, Department of Surgery; Assistant Cancer Center Director, Surgery, Yale Cancer ... Associate Professor of Orthopaedics and Rehabilitation; Disease Aligned Research Team Leader, Sarcoma Program, Yale Cancer ... Associate Professor of Orthopaedics and Rehabilitation; Disease Aligned Research Team Leader, Sarcoma Program, Yale Cancer ...
more infohttps://www.yalecancercenter.org/patient/programs/sarcoma/members/

The Ottawa Hospital Foundation | Ottawa Business JournalThe Ottawa Hospital Foundation | Ottawa Business Journal

Research in regenerative medicine, cancer, and to improve patient care.. *Cancer care equipment and facilities. ... cancer care for the region. We provide the best care to the sickest patients and to those with the most complex health-care ... Funds raised will be allocated to research on regenerative medicine, cancer, and improving patient care. We have raised $38m to ... To do so, we must continue to fund research, equipment and care - not all of which is covered by the province. This is when we ...
more infohttp://www.obj.ca/node/21316

Browsing Publications by SubjectBrowsing Publications by Subject

Cancer Care Facilities [‎2]‎. Cannabis [‎6]‎. Capacity Building [‎22]‎. Cape Verde [‎1]‎. ...
more infohttps://extranet.who.int/iris/restricted/handle/10665/26724/browse?rpp=20&etal=-1&sort_by=-1&type=mesh&starts_with=C&order=ASC

Italy supports West Bank cancer care center for Palestinians | Al BawabaItaly supports West Bank cancer care center for Palestinians | Al Bawaba

A new cancer care facility has opened at Beit Jala Government Hospital in the West Bank with support from the Government of ... A new cancer care facility has opened at Beit Jala Government Hospital in the West Bank with support from the Government of ... Italy supports West Bank cancer care center for Palestinians. Italy supports West Bank cancer care center for Palestinians 2.5 ... He described the cancer center as a pillar for Palestinian health institutions, since its medical services will reach all ...
more infohttps://www.albawaba.com/business/italy-supports-west-bank-cancer-care-center-palestinians?quicktabs_accordion=0

Advanced Search Results - Public Health Image Library(PHIL)Advanced Search Results - Public Health Image Library(PHIL)

Categories: Cancer Care Facilities Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
more infohttps://phil.cdc.gov/AdvancedSearchResults.aspx?Search=Cancer+Care+Facilities&parentid=13174&catid=5212

2010 Cancer Care Annual Report by Childrens Mercy Hospital"2010 Cancer Care Annual Report" by Children's Mercy Hospital

Annual report of cancer care and oncology services at the Childrens Mercy Hospital, Kansas City MO, a pediatric medical center ... Cancer Care Facilities; Hepatoblastoma; Neoplasms; Hospitals, Pediatric; Annual Reports; Oncologists. Keywords. cancer; ... "2010 Cancer Care Annual Report" (2010). Cancer Center Annual Reports. 5. https://scholarlyexchange.childrensmercy.org/cancer_ ... Annual report of cancer care and oncology services at the Childrens Mercy Hospital, Kansas City MO, a pediatric medical center ...
more infohttps://scholarlyexchange.childrensmercy.org/cancer_center_annual_reports/5/

2012 Cancer Care Annual Report by Childrens Mercy Hospital"2012 Cancer Care Annual Report" by Children's Mercy Hospital

Annual report of cancer care and oncology services at the Childrens Mercy Hospital, Kansas City MO, a pediatric medical center ... Cancer Care Facilities; Brain Neoplasms; Hospitals, Pediatric; Annual Reports; Oncologists. Keywords. cancer; pediatrics; ... "2012 Cancer Care Annual Report" (2012). Cancer Center Annual Reports. 3. https://scholarlyexchange.childrensmercy.org/cancer_ ... Annual report of cancer care and oncology services at the Childrens Mercy Hospital, Kansas City MO, a pediatric medical center ...
more infohttps://scholarlyexchange.childrensmercy.org/cancer_center_annual_reports/3/
AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Health FacilitiesSkilled Nursing FacilitiesEarly Detection of CancerResidential FacilitiesProstatic NeoplasmsOvarian NeoplasmsBreast NeoplasmsLung NeoplasmsStomach NeoplasmsColonic NeoplasmsAmbulatory Care FacilitiesFacility Design and ConstructionNeoplasm MetastasisNeoplasm InvasivenessUnited StatesNeoplasmsPancreatic NeoplasmsAssisted Living FacilitiesGene Expression Regulation, NeoplasticMice, NudeCancer VaccinesHealth Facility AdministrationRetrospective StudiesHealth Facilities, ProprietaryNeoplasm ProteinsUterine Cervical NeoplasmsSurvival AnalysisSurvival RatePublic FacilitiesHealth Facility PlanningPrognosisGenetic Predisposition to DiseaseProspective StudiesFollow-Up StudiesRiskAntineoplastic AgentsFacility Regulation and ControlRegistriesAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmCarcinoma, Squamous CellCarcinomaDisease ProgressionReverse Transcriptase Polymerase Chain ReactionRisk AssessmentUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungNational Cancer Institute (U.S.)QuestionnairesColorectal NeoplasmsCell Line, TumorGene Expression ProfilingReceptors, EstrogenXenograft Model Antitumor AssaysAge FactorsLong-Term CareTumor Markers, BiologicalNeoplasm StagingMutationSurvivorsOdds RatioRNA, MessengerRisk FactorsReceptor, erbB-2Rectal NeoplasmsNursing HomesNeoplasm Recurrence, LocalCombined Modality TherapyBlotting, WesternMultivariate AnalysisSensitivity and SpecificityNeoplasm TransplantationDisease-Free SurvivalProstate-Specific AntigenDNA, NeoplasmMammographyCell Transformation, NeoplasticEndometrial NeoplasmsSmokingRNA, Small InterferingLogistic ModelsDNA MethylationHealth Services AccessibilityAqueous HumorChemotherapy, AdjuvantMedical OncologyCell SurvivalToilet FacilitiesTumor Suppressor Protein p53Esophageal NeoplasmsFluorouracilMilitary FacilitiesGenotypeTamoxifenTransplantation, HeterologousNeoplastic Stem CellsJapanKaplan-Meier EstimateCisplatinReceptors, ProgesteroneAntineoplastic Agents, PhytogenicOligonucleotide Array Sequence AnalysisReproducibility of ResultsCell MovementGenes, BRCA1Antineoplastic Agents, HormonalDown-RegulationAntigens, NeoplasmSEER ProgramBreastDose-Response Relationship, DrugLiver NeoplasmsIncidenceClinical Trials as TopicAdenocarcinomaTumor BurdenDrug Screening Assays, AntitumorHead and Neck NeoplasmsCancer Care FacilitiesCell DivisionAnticarcinogenic AgentsPredictive Value of TestsNeoplasms, Radiation-InducedMouth NeoplasmsConfidence IntervalsNeoplasms, Hormone-DependentTreatment OutcomePolymorphism, GeneticCell CycleHomes for the AgedMolecular Targeted TherapyCarcinoma, Small CellCross-Sectional StudiesPaclitaxelOccupational ExposurePolymerase Chain ReactionCell ProliferationCell Growth ProcessesApoptosisPromoter Regions, GeneticQuality of LifeAmerican Cancer SocietyBone NeoplasmsReceptor, Epidermal Growth FactorRadiotherapyNeoplasms, Second PrimaryMicroRNAsTransfectionChinaProstateNeoplasms, Glandular and EpithelialRNA InterferenceAntibodies, MonoclonalNeovascularization, PathologicTumor Suppressor ProteinsUp-RegulationModels, BiologicalGene SilencingIntermediate Care FacilitiesSkin NeoplasmsGenes, Tumor SuppressorTumor Cells, CulturedTime FactorsGenital Neoplasms, FemaleDeoxycytidineTrabecular MeshworkGerm-Line MutationPrecancerous ConditionsGenes, NeoplasmNeoplasm GradingMice, SCIDDietTissue Array AnalysisGastrointestinal NeoplasmsAge DistributionPalliative CareAntimetabolites, AntineoplasticQuality of Health CareBase SequenceGenes, p53Receptors, AndrogenAnimals, LaboratoryPostmenopausePrevalenceSocioeconomic FactorsMaternal Health ServicesHealth Facility EnvironmentMolecular Sequence DataTaxoidsHCT116 CellsDrug Administration ScheduleMCF-7 CellsThyroid NeoplasmsRNA, NeoplasmDNA-Binding ProteinsEuropean Continental Ancestry GroupFlow CytometryOccupational DiseasesGene ExpressionImmunoenzyme TechniquesGene Knockdown Techniques
Palliative Care2017CentersOncologistsOncologyDiagnosisAcuteComplementary and alteGynecologicDiagnoseMultidisciplinaryOutpatient clinicCentre2018CardiacStriveMedicalPatient careLaboratorySearchHealthAdultObjectivesHealthcareAwarenessAdvancesHigh qualityProgramTreatNationallyRadiationExperienceCommittee

Palliative Care2

search

20174

search

Centers8

search

Oncologists1

search

Oncology4

search

Diagnosis4

search

Acute4

search
  • CPR was successful in all eight patients in which cardiac arrest was the consequence of an acute cardiovascular drug toxicity, even if cancer was metastatic and treatment intent not curative, while it was effective in only 25% of those in which cardiac arrest was an ultimate complication of various problems, like septic shock or respiratory failure complicating the neoplastic disease. (biomedsearch.com)
  • In cancer as in other types of disease, CPR is mainly indicated when cardiac arrest is the consequence of and acute insult. (biomedsearch.com)
  • Specializing in acute care for adults, we are the region's only trauma center and the hub of cancer care for the region. (obj.ca)
  • The bigger facility not only increases access to urgent treatment for acute illnesses and injuries for the community, but it also brings the academic health system one essential step closer toward offering adult trauma care on the South Side of Chicago, pending state regulatory approval. (uchicago.edu)

Complementary and alte2

search
  • GOALS OF WORK: Therapeutic touch (TT) is a complementary and alternative medicine (CAM) treatment modeled on the ancient practice of 'laying on of hands' that has been developed into a contemporary supportive care intervention. (isharonline.org)
  • About 40-50 % of cancer patients use complementary and alternative medicine (CAM). (nih.gov)

Gynecologic1

search

Diagnose2

search

Multidisciplinary2

search

Outpatient clinic1

search
  • It offers comprehensive adult and paediatric services, including day care and an outpatient clinic, a tissue pathology laboratory, and a diagnostic endoscopy unit for examining internal organs. (albawaba.com)

Centre4

search

20182

search

Cardiac1

search

Strive3

search

Medical2

search

Patient care3

search

Laboratory1

search
  • which developed and validated an IHC laboratory in support of a growing cancer care service. (who.int)

Search1

search
  • WHO HQ Library catalog › Results of search for 'su:{Cancer care facilities. (who.int)

Health10

search
  • More and more, we're finding that patients and their families want to know how the health care institutions in their communities compare with one another," said Lawrence N. Shulman, MD, FACP, Chair of the CoC. (facs.org)
  • They also consulted with a "Whole Person Health Design Team" comprised of ProHealth Care staffers. (archdaily.com)
  • What we learned was that people are willing to make trade-offs in order to have access to affordable health care," the company said. (spokesman.com)
  • The Ministry of Public Health, HMC, and Primary Health Care Corporation have partnered again this year to re-launch the Ramadan Health website and expanded the initiative by introducing a companion smartphone and tablet app. (gulf-times.com)
  • We provide the best care to the sickest patients and to those with the most complex health-care issues, with the compassion that aims to treat you like a loved one and make you feel at home. (obj.ca)
  • Our researchers are investigating every major disease and re-shaping health care, replacing existing ways of being treated with new, better methods. (obj.ca)
  • Throughout the coming decade, we will embark on a quest that will change Ottawa's health care landscape for the next century. (obj.ca)
  • The funds are part of a $9.4 million contribution from Italy to improve the quality of health care for Palestinians in the occupied territories. (albawaba.com)
  • Visitors talk to Selwyn Rogers, executive vice president for community health engagement, as they tour the new facility. (uchicago.edu)
  • Plans for the new, 65-bed, $4.7 million facility were approved by the Oregon Health Commission in December 1975. (wikipedia.org)

Adult1

search
  • The University of Chicago Medicine celebrated the completion of what will be the city's newest and most advanced adult emergency department when the $39 million facility opens to patients in late December. (uchicago.edu)

Objectives2

search
  • Once the objectives became clear, Cannon set about finding the right design solutions and materials to create this treatment facility. (archdaily.com)
  • PURPOSE/OBJECTIVES: To explore the meanings and uses of an expressed desire for hastened death in seven patients living with advanced cancer. (isharonline.org)

Healthcare1

search

Awareness2

search

Advances1

search

High quality3

search
  • Each of these facilities has committed itself to continuous quality assessment and improvement, and has proved that this approach yields the high quality cancer care that all of our patients should expect," Dr. Shulman said. (facs.org)
  • We pride ourselves on our patient-centered approach, which allows us to offer high-quality care. (mckesson.com)
  • Bringing Arizona Oncology's expertise and innovative technology to the prestigious ASURP is a tremendous addition for East Valley residents needing high-quality care," said Molly Ryan Carson, vice president of Development at Ryan. (mckesson.com)

Program4

search
  • Award recipients must have received commendation ratings in all seven commendation standards, in addition to receiving a compliance rating for each of the 27 remaining cancer program standards. (facs.org)
  • Through this recognition program, I'd like to think we're playing a small, but vital role, in helping them make informed decisions on their cancer care. (facs.org)
  • Focuses on the Children's Mercy Brain Tumor Program, features cancer registry. (childrensmercy.org)
  • New scientific discoveries by Christiana Care's Cancer Research Program are constantly changing what we know about cancer and how it is most effectively treated. (asbestos.com)

Treat1

search
  • Patients will end up having to wait while we treat others with more serious conditions so we recommend these patients to visit their primary care doctor. (gulf-times.com)

Nationally1

search
  • Each of these facilities is not just meeting nationally recognized standards for the delivery of quality cancer care, they are exceeding them. (facs.org)

Radiation1

search
  • The facility will have two treatment vaults for radiation, a room dedicated to PET-CT scanning, 35 infusion chairs with personal tablets, 19 exam rooms, a covered patio with peaceful waterfalls, and a nursing station with semi-private scheduling areas. (mckesson.com)

Experience1

search

Committee1

search
  • The International cancer patient data exchange system : a project of the Committee on International Collaborative Activities (CICA, two year progress report. (who.int)